false--12-31 Q1 2020 0000844965 47000000 5262000 6308000 0.01 0.01 250000000 250000000 128304354 128693692 0.0725 0.0750 0.0725 1700000 6400000 1500000 6200000 88422000 89450000 295900000 0 0 0 0 P9M P1Y P1Y P1Y P1Y 2823191 2896627 5800000 2800000 9500000 1000000 900000 5600000 2600000 9200000 1300000 800000 0000844965 2020-01-01 2020-03-31 0000844965 2020-05-06 0000844965 2019-01-01 2019-03-31 0000844965 us-gaap:ProductMember 2019-01-01 2019-03-31 0000844965 us-gaap:ProductMember 2020-01-01 2020-03-31 0000844965 us-gaap:ServiceMember 2019-01-01 2019-03-31 0000844965 us-gaap:ServiceMember 2020-01-01 2020-03-31 0000844965 2019-12-31 0000844965 2020-03-31 0000844965 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0000844965 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0000844965 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000844965 us-gaap:NoncontrollingInterestMember 2019-03-31 0000844965 us-gaap:RetainedEarningsMember 2019-03-31 0000844965 2019-03-31 0000844965 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000844965 tti:CommonStockValueMember 2018-12-31 0000844965 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000844965 us-gaap:NoncontrollingInterestMember 2018-12-31 0000844965 2018-12-31 0000844965 us-gaap:TreasuryStockMember 2018-12-31 0000844965 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000844965 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000844965 us-gaap:TreasuryStockMember 2019-03-31 0000844965 tti:CommonStockValueMember 2019-03-31 0000844965 us-gaap:RetainedEarningsMember 2018-12-31 0000844965 tti:CommonStockValueMember 2019-01-01 2019-03-31 0000844965 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0000844965 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000844965 tti:CommonStockValueMember 2020-03-31 0000844965 us-gaap:TreasuryStockMember 2019-12-31 0000844965 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000844965 us-gaap:RetainedEarningsMember 2020-03-31 0000844965 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0000844965 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000844965 us-gaap:TreasuryStockMember 2020-03-31 0000844965 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000844965 tti:CommonStockValueMember 2019-12-31 0000844965 us-gaap:NoncontrollingInterestMember 2019-12-31 0000844965 us-gaap:NoncontrollingInterestMember 2020-03-31 0000844965 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000844965 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000844965 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000844965 tti:CommonStockValueMember 2020-01-01 2020-03-31 0000844965 us-gaap:RetainedEarningsMember 2019-12-31 0000844965 country:US tti:CompletionFluidsProductsDivisionMember 2020-01-01 2020-03-31 0000844965 country:US tti:WaterFlowbackServicesMember 2020-01-01 2020-03-31 0000844965 us-gaap:NonUsMember tti:WaterFlowbackServicesMember 2019-01-01 2019-03-31 0000844965 us-gaap:NonUsMember tti:CompletionFluidsProductsDivisionMember 2020-01-01 2020-03-31 0000844965 country:US tti:CompressionMember 2019-01-01 2019-03-31 0000844965 us-gaap:NonUsMember tti:CompressionMember 2019-01-01 2019-03-31 0000844965 country:US 2020-01-01 2020-03-31 0000844965 tti:WaterFlowbackServicesMember 2020-01-01 2020-03-31 0000844965 us-gaap:NonUsMember tti:CompressionMember 2020-01-01 2020-03-31 0000844965 country:US 2019-01-01 2019-03-31 0000844965 us-gaap:NonUsMember 2020-01-01 2020-03-31 0000844965 us-gaap:NonUsMember tti:CompletionFluidsProductsDivisionMember 2019-01-01 2019-03-31 0000844965 tti:CompletionFluidsProductsDivisionMember 2019-01-01 2019-03-31 0000844965 tti:CompressionMember 2019-01-01 2019-03-31 0000844965 tti:CompletionFluidsProductsDivisionMember 2020-01-01 2020-03-31 0000844965 tti:WaterFlowbackServicesMember 2019-01-01 2019-03-31 0000844965 us-gaap:NonUsMember 2019-01-01 2019-03-31 0000844965 us-gaap:NonUsMember tti:WaterFlowbackServicesMember 2020-01-01 2020-03-31 0000844965 country:US tti:CompletionFluidsProductsDivisionMember 2019-01-01 2019-03-31 0000844965 country:US tti:CompressionMember 2020-01-01 2020-03-31 0000844965 country:US tti:WaterFlowbackServicesMember 2019-01-01 2019-03-31 0000844965 tti:CompressionMember 2020-01-01 2020-03-31 0000844965 2020-04-01 2020-03-31 0000844965 2022-01-01 2020-03-31 0000844965 2024-01-01 2020-03-31 0000844965 2023-01-01 2020-03-31 0000844965 2021-01-01 2020-03-31 0000844965 srt:MinimumMember 2020-01-01 2020-03-31 0000844965 srt:MaximumMember 2020-01-01 2020-03-31 0000844965 srt:ParentCompanyMember 2019-12-31 0000844965 tti:TermLoanMember us-gaap:SecuredDebtMember 2019-12-31 0000844965 tti:CSICompresscoMember 2019-12-31 0000844965 tti:CompresscoPartnersSeniorNotesMember 2019-12-31 0000844965 tti:NewCreditAgreementMember 2019-12-31 0000844965 tti:CompresscoPartnersSeniorNotesMember 2020-03-31 0000844965 tti:NewCreditAgreementMember 2020-03-31 0000844965 tti:TermLoanMember us-gaap:SecuredDebtMember 2020-03-31 0000844965 us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredDebtMember 2020-03-31 0000844965 srt:ParentCompanyMember 2020-03-31 0000844965 tti:CompresscoPartnersSeniorNotes7.50Member 2020-03-31 0000844965 tti:CSICompresscoMember 2020-03-31 0000844965 tti:CompresscoPartnersSeniorNotes7.50Member 2019-12-31 0000844965 us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredDebtMember 2019-12-31 0000844965 srt:ParentCompanyMember us-gaap:LineOfCreditMember 2020-03-31 0000844965 tti:CSICompresscoMember tti:CompresscoPartnersSeniorNotes7.50Member 2020-03-31 0000844965 tti:CSICompresscoMember tti:CompresscoPartnersSeniorNotesMember 2020-03-31 0000844965 tti:CSICompresscoMember tti:CompresscoPartnersSeniorNotes7.50Member 2019-12-31 0000844965 tti:CSICompresscoMember tti:CompresscoPartnersSeniorNotesMember 2019-12-31 0000844965 tti:OffshoreServicesMember 2020-01-01 2020-03-31 0000844965 tti:MaritechMember 2020-01-01 2020-03-31 0000844965 tti:OffshoreServicesMember 2019-01-01 2019-03-31 0000844965 tti:MaritechMember 2019-01-01 2019-03-31 0000844965 tti:MaritechMember 2019-12-31 0000844965 tti:OffshoreServicesMember 2019-12-31 0000844965 tti:OffshoreServicesMember 2020-03-31 0000844965 tti:MaritechMember 2020-03-31 0000844965 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember tti:OffshoreDivisionMember 2019-08-31 0000844965 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember tti:OffshoreDivisionMember 2018-03-01 0000844965 tti:ForwardPurchaseContractEuroSwedishKronaNotionalAmountMember 2020-01-01 2020-03-31 0000844965 tti:ForwardPurchaseContractEuroSwedishKronaNotionalAmount3Member 2020-01-01 2020-03-31 0000844965 tti:ForwardPurchaseContractEuroSwedishKronaNotionalAmount2Member 2020-03-31 0000844965 tti:ForwardPurchaseContractEuroSwedishKronaNotionalAmountMember 2020-03-31 0000844965 tti:ForwardPurchaseContractEuroSwedishKronaNotionalAmount2Member 2020-01-01 2020-03-31 0000844965 tti:ForwardPurchaseContractEuroSwedishKronaNotionalAmount3Member 2020-03-31 0000844965 tti:ForwardPurchaseContractEuroBritishPoundNotionalAmountMember 2020-03-31 0000844965 tti:ForwardPurchaseContractEuroBritishPoundNotionalAmountMember 2020-01-01 2020-03-31 0000844965 us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000844965 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000844965 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000844965 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000844965 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000844965 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000844965 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000844965 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000844965 us-gaap:OtherCurrentAssetsMember 2019-12-31 0000844965 us-gaap:OtherCurrentAssetsMember 2020-03-31 0000844965 us-gaap:OtherLiabilitiesMember 2019-12-31 0000844965 us-gaap:OtherLiabilitiesMember 2020-03-31 0000844965 tti:ForwardSaleContractPoundsSterlingMember 2020-01-01 2020-03-31 0000844965 tti:ForwardSaleContractPoundsSterlingTwoMember 2020-03-31 0000844965 tti:ForwardPurchaseContractEuroMember 2020-03-31 0000844965 tti:ForwardPurchaseContractPoundsSterlingMember 2020-03-31 0000844965 tti:ForwardSaleContractMexicanPesos2Member 2020-03-31 0000844965 tti:ForwardSaleContractNorwegiankroneDomain 2020-03-31 0000844965 tti:ForwardSaleContractNorwegiankroneDomain 2020-01-01 2020-03-31 0000844965 tti:ForwardPurchaseContractEuroMember 2020-01-01 2020-03-31 0000844965 tti:ForwardPurchaseContractPoundsSterlingMember 2020-01-01 2020-03-31 0000844965 tti:ForwardSaleContractPoundsSterlingMember 2020-03-31 0000844965 tti:ForwardSaleContractMexicanPesos2Member 2020-01-01 2020-03-31 0000844965 tti:ForwardPurchaseContractEurosTwoMember 2020-01-01 2020-03-31 0000844965 tti:ForwardPurchaseContractEurosTwoMember 2020-03-31 0000844965 tti:ForwardPurchaseContractNorwegianKroneMember 2020-03-31 0000844965 tti:ForwardSaleContractPoundsSterlingTwoMember 2020-01-01 2020-03-31 0000844965 tti:ForwardPurchaseContractNorwegianKroneMember 2020-01-01 2020-03-31 0000844965 us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:FairValueInputsLevel3Member us-gaap:MandatorilyRedeemablePreferredStockMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:FairValueInputsLevel1Member us-gaap:MandatorilyRedeemablePreferredStockMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:FairValueInputsLevel2Member us-gaap:MandatorilyRedeemablePreferredStockMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:MandatorilyRedeemablePreferredStockMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000844965 us-gaap:ProductMember tti:CompletionFluidsProductsDivisionMember 2020-01-01 2020-03-31 0000844965 tti:CorporateOverheadMember 2020-01-01 2020-03-31 0000844965 us-gaap:ProductMember tti:CompressionMember 2019-01-01 2019-03-31 0000844965 tti:InterdivisionEliminationsMember 2020-01-01 2020-03-31 0000844965 us-gaap:ServiceMember tti:CompressionMember 2019-01-01 2019-03-31 0000844965 tti:InterdivisionEliminationsMember 2019-01-01 2019-03-31 0000844965 us-gaap:ProductMember tti:WaterFlowbackServicesMember 2019-01-01 2019-03-31 0000844965 us-gaap:ServiceMember tti:CompletionFluidsProductsDivisionMember 2019-01-01 2019-03-31 0000844965 us-gaap:ProductMember tti:WaterFlowbackServicesMember 2020-01-01 2020-03-31 0000844965 tti:CorporateOverheadMember 2019-01-01 2019-03-31 0000844965 us-gaap:ServiceMember tti:WaterFlowbackServicesMember 2019-01-01 2019-03-31 0000844965 us-gaap:ServiceMember tti:WaterFlowbackServicesMember 2020-01-01 2020-03-31 0000844965 us-gaap:ProductMember tti:CompletionFluidsProductsDivisionMember 2019-01-01 2019-03-31 0000844965 us-gaap:ServiceMember tti:CompressionMember 2020-01-01 2020-03-31 0000844965 us-gaap:ServiceMember tti:CompletionFluidsProductsDivisionMember 2020-01-01 2020-03-31 0000844965 us-gaap:ProductMember tti:CompressionMember 2020-01-01 2020-03-31 0000844965 tti:SeniorSecuredSecondLienNotesDue2027Member us-gaap:SubsequentEventMember 2020-04-17 0000844965 tti:CSICompresscoMember tti:CompresscoPartnersSeniorNotesMember us-gaap:SubsequentEventMember 2020-04-17 0000844965 tti:SeniorSecuredFirstLienNotesDue2025Member us-gaap:SubsequentEventMember 2020-04-17 iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2020
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
Commission File Number 1-13455
TETRA Technologies, Inc.
(Exact name of registrant as specified in its charter)

Delaware | 74-2148293
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.)
24955 Interstate 45 North |
The Woodlands, |
Texas | 77380
(Address of Principal Executive Offices) | (Zip Code)

(281) 367-1983
(Registrant’s Telephone Number, Including Area Code)
_______________________________________________________________________
Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock | TTI | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☐ | Accelerated filer | ☒
Non-accelerated filer | ☐ | Smaller reporting company | ☒
|  | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of May 5, 2020, there were 125,898,683 shares outstanding of the Company’s Common Stock, $0.01 par value per share.

TETRA Technologies, Inc. and Subsidiaries
Table of Contents
| Page
PART I—FINANCIAL INFORMATION |
Item 1. Financial Statements |
Consolidated Statements of Operations | 1
Consolidated Statements of Comprehensive Income (Loss) | 2
Consolidated Balance Sheets | 3
Consolidated Statements of Equity | 5
Consolidated Statements of Cash Flows | 6
Notes to Consolidated Financial Statements | 7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 22
Item 3. Quantitative and Qualitative Disclosures about Market Risk | 35
Item 4. Controls and Procedures | 35
PART II—OTHER INFORMATION |
Item 1. Legal Proceedings | 35
Item 1A. Risk Factors | 36
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 37
Item 3. Defaults Upon Senior Securities | 37
Item 4. Mine Safety Disclosures | 37
Item 5. Other Information | 37
Item 6. Exhibits | 38
SIGNATURES | 39

Table of Contents
PART I
FINANCIAL INFORMATION
Item 1. Financial Statements.
TETRA Technologies, Inc. and Subsidiaries
Consolidated Statements of Operations
(In Thousands, Except Per Share Amounts)
(Unaudited)

| Three Months Ended March 31,
| 2020 |  | 2019
Revenues: |  |  |
Product sales | $ | 85,033 |  |  | $ | 91,781 |
Services | 137,909 |  |  | 151,947 |
Total revenues | 222,942 |  |  | 243,728 |
Cost of revenues: |  |  |
Cost of product sales | 58,967 |  |  | 74,588 |
Cost of services | 89,727 |  |  | 102,156 |
Depreciation, amortization, and accretion | 29,460 |  |  | 30,628 |
Impairments and other charges | 5,371 |  |  | 146 |
Total cost of revenues | 183,525 |  |  | 207,518 |
Gross profit | 39,417 |  |  | 36,210 |
General and administrative expense | 30,537 |  |  | 34,277 |
Interest expense, net | 17,856 |  |  | 18,379 |
Warrants fair value adjustment (income) expense | (338 | ) |  | 407 |
CCLP Series A Preferred Units fair value adjustment (income) expense | — |  |  | 1,163 |
Other (income) expense, net | 439 |  |  | (951 | )
Loss before taxes and discontinued operations | (9,077 | ) |  | (17,065 | )
Provision for income taxes | 1,154 |  |  | 1,609 |
Loss before discontinued operations | (10,231 | ) |  | (18,674 | )
Discontinued operations: |  |  |
Loss from discontinued operations, net of taxes | (145 | ) |  | (426 | )
Net loss | (10,376 | ) |  | (19,100 | )
Less: loss attributable to noncontrolling interest | 8,825 |  |  | 8,262 |
Net loss attributable to TETRA stockholders | $ | (1,551 | ) |  | $ | (10,838 | )
Basic net loss per common share: |  |  |
Loss before discontinued operations attributable to TETRA stockholders | $ | (0.01 | ) |  | $ | (0.09 | )
Loss from discontinued operations attributable to TETRA stockholders | $ | 0.00 |  |  | $ | 0.00 |
Net loss attributable to TETRA stockholders | $ | (0.01 | ) |  | $ | (0.09 | )
Average shares outstanding | 125,587 |  |  | 125,681 |
Diluted net loss per common share: |  |  |
Loss before discontinued operations attributable to TETRA stockholders | $ | (0.01 | ) |  | $ | (0.09 | )
Loss from discontinued operations attributable to TETRA stockholders | $ | 0.00 |  |  | $ | 0.00 |
Net loss attributable to TETRA stockholders | $ | (0.01 | ) |  | $ | (0.09 | )
Average diluted shares outstanding | 125,587 |  |  | 125,681 |

See Notes to Consolidated Financial Statements
1

Table of Contents
TETRA Technologies, Inc. and Subsidiaries
Consolidated Statements of Comprehensive Income (Loss)
(In Thousands)
(Unaudited)

| Three Months Ended March 31,
| 2020 |  | 2019
Net loss | $ | (10,376 | ) |  | $ | (19,100 | )
Foreign currency translation adjustment, net of taxes of $0 in 2020 and 2019 | (6,467 | ) |  | (406 | )
Comprehensive loss | (16,843 | ) |  | (19,506 | )
Less: Comprehensive loss attributable to noncontrolling interest | 9,054 |  |  | 8,086 |
Comprehensive loss attributable to TETRA stockholders | $ | (7,789 | ) |  | $ | (11,420 | )

See Notes to Consolidated Financial Statements
2

Table of Contents
TETRA Technologies, Inc. and Subsidiaries
Consolidated Balance Sheets
(In Thousands)

| March 31, 2020 |  | December 31, 2019
| (Unaudited) |  |  |
ASSETS |  |  |  |  |
Current assets: |  |  |  |  |
Cash and cash equivalents | $ | 29,473 |  |  | $ | 17,704 |
Restricted cash | 53 |  |  | 64 |
Trade accounts receivable, net of allowances of $6,308 in 2020 and $5,262 in 2019 | 169,231 |  |  | 176,291 |
Inventories | 142,116 |  |  | 136,510 |
Prepaid expenses and other current assets | 23,107 |  |  | 20,785 |
Total current assets | 363,980 |  |  | 351,354 |
Property, plant, and equipment: |  |  |  |  |
Land and building | 57,357 |  |  | 60,586 |
Machinery and equipment | 1,347,642 |  |  | 1,335,157 |
Automobiles and trucks | 30,052 |  |  | 31,681 |
Chemical plants | 58,327 |  |  | 57,692 |
Construction in progress | 24,760 |  |  | 34,393 |
Total property, plant, and equipment | 1,518,138 |  |  | 1,519,509 |
Less accumulated depreciation | (777,891 | ) |  | (760,872 | )
Net property, plant, and equipment | 740,247 |  |  | 758,637 |
Other assets: |  |  |  |  |
Patents, trademarks and other intangible assets, net of accumulated amortization of $89,450 in 2020 and $88,422 in 2019 | 72,104 |  |  | 74,199 |
Deferred tax assets, net | 24 |  |  | 24 |
Operating lease right-of-use assets | 75,344 |  |  | 68,131 |
Other assets | 18,065 |  |  | 19,577 |
Total other assets | 165,537 |  |  | 161,931 |
Total assets | $ | 1,269,764 |  |  | $ | 1,271,922 |

See Notes to Consolidated Financial Statements
3

Table of Contents
TETRA Technologies, Inc. and Subsidiaries
Consolidated Balance Sheets
(In Thousands, Except Share Amounts)

| March 31, 2020 |  | December 31, 2019
| (Unaudited) |  |  |
LIABILITIES AND EQUITY |  |  |  |  |
Current liabilities: |  |  |  |  |
Trade accounts payable | $ | 88,204 |  |  | $ | 88,917 |
Unearned income | 28,422 |  |  | 9,831 |
Accrued liabilities and other | 76,559 |  |  | 87,877 |
Liabilities of discontinued operations | 2,011 |  |  | 2,098 |
Total current liabilities | 195,196 |  |  | 188,723 |
Long-term debt, net | 845,842 |  |  | 842,871 |
Deferred income taxes | 2,762 |  |  | 2,988 |
Asset retirement obligations | 12,878 |  |  | 12,762 |
Warrants liability | 112 |  |  | 449 |
Operating lease liabilities | 59,845 |  |  | 53,919 |
Other liabilities | 6,198 |  |  | 7,384 |
Total long-term liabilities | 927,637 |  |  | 920,373 |
Commitments and contingencies |  |  |  |  |
Equity: |  |  |  |  |
TETRA stockholders' equity: |  |  |  |  |
Common stock, par value $0.01 per share; 250,000,000 shares authorized at March 31, 2020 and December 31, 2019; 128,693,692 shares issued at March 31, 2020 and 128,304,354 shares issued at December 31, 2019 | 1,287 |  |  | 1,283 |
Additional paid-in capital | 468,088 |  |  | 466,959 |
Treasury stock, at cost; 2,896,627 shares held at March 31, 2020, and 2,823,191 shares held at December 31, 2019 | (19,253 | ) |  | (19,164 | )
Accumulated other comprehensive income (loss) | (58,421 | ) |  | (52,183 | )
Retained deficit | (364,073 | ) |  | (362,522 | )
Total TETRA stockholders' equity | 27,628 |  |  | 34,373 |
Noncontrolling interests | 119,303 |  |  | 128,453 |
Total equity | 146,931 |  |  | 162,826 |
Total liabilities and equity | $ | 1,269,764 |  |  | $ | 1,271,922 |

See Notes to Consolidated Financial Statements
4

Table of Contents
TETRA Technologies, Inc. and Subsidiaries
Consolidated Statements of Equity
(In Thousands)

| Common Stock Par Value |  | Additional Paid-In Capital |  | Treasury Stock |  | Accumulated Other Comprehensive Income (Loss) |  | Retained Earnings |  | Noncontrolling Interest |  | Total Equity
|  |  |  | Currency Translation |  |  |
Balance at December 31, 2019 | $ | 1,283 |  |  | $ | 466,959 |  |  | $ | (19,164 | ) |  | $ | (52,183 | ) |  | $ | (362,522 | ) |  | $ | 128,453 |  |  | $ | 162,826 |
Net loss for first quarter 2020 | — |  |  | — |  |  | — |  |  | — |  |  | (1,551 | ) |  | (8,825 | ) |  | (10,376 | )
Translation adjustment, net of taxes of $0 | — |  |  | — |  |  | — |  |  | (6,238 | ) |  | — |  |  | (229 | ) |  | (6,467 | )
Comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (16,843 | )
Distributions to public unitholders | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (309 | ) |  | (309 | )
Equity award activity | 4 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 4 |
Treasury stock activity, net | — |  |  | — |  |  | (89 | ) |  | — |  |  | — |  |  | — |  |  | (89 | )
Equity compensation expense | — |  |  | 1,145 |  |  | — |  |  | — |  |  | — |  |  | 228 |  |  | 1,373 |
Other | — |  |  | (16 | ) |  | — |  |  | — |  |  | — |  |  | (15 | ) |  | (31 | )
Balance at March 31, 2020 | $ | 1,287 |  |  | $ | 468,088 |  |  | $ | (19,253 | ) |  | $ | (58,421 | ) |  | $ | (364,073 | ) |  | $ | 119,303 |  |  | $ | 146,931 |

| Common Stock Par Value |  | Additional Paid-In Capital |  | Treasury Stock |  | Accumulated Other Comprehensive Income (Loss) |  | Retained Earnings |  | Noncontrolling Interest |  | Total Equity
|  |  |  | Currency Translation |  |  |
Balance at December 31, 2018 | $ | 1,285 |  |  | $ | 460,680 |  |  | $ | (18,950 | ) |  | $ | (51,663 | ) |  | $ | (217,952 | ) |  | $ | 139,349 |  |  | $ | 312,749 |
Net loss for first quarter 2019 | — |  |  | — |  |  | — |  |  | — |  |  | (10,838 | ) |  | (8,262 | ) |  | (19,100 | )
Translation adjustment, net of taxes of $0 | — |  |  | — |  |  | — |  |  | (582 | ) |  | — |  |  | 176 |  |  | (406 | )
Comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (19,506 | )
Distributions to public unitholders | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (307 | ) |  | (307 | )
Equity award activity | (1 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1 | )
Treasury stock activity, net | — |  |  | — |  |  | (155 | ) |  | — |  |  | — |  |  | — |  |  | (155 | )
Equity compensation expense | — |  |  | 1,628 |  |  | — |  |  | — |  |  | — |  |  | 311 |  |  | 1,939 |
Conversions of CCLP Series A Preferred | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,539 |  |  | 2,539 |
Cumulative effect adjustment | — |  |  | — |  |  | — |  |  | — |  |  | 2,843 |  |  | — |  |  | 2,843 |
Other | — |  |  | (67 | ) |  | — |  |  | — |  |  | — |  |  | 76 |  |  | 9 |
Balance at March 31, 2019 | $ | 1,284 |  |  | $ | 462,241 |  |  | $ | (19,105 | ) |  | $ | (52,245 | ) |  | $ | (225,947 | ) |  | $ | 133,882 |  |  | $ | 300,110 |

See Notes to Consolidated Financial Statements
5

Table of Contents
TETRA Technologies, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(In Thousands)
(Unaudited)

| Three Months Ended March 31,
| 2020 |  | 2019
Operating activities: |  |  |  |  |
Net loss | $ | (10,376 | ) |  | $ | (19,100 | )
Reconciliation of net loss to cash provided by operating activities: |  |  |
Depreciation, amortization, and accretion | 29,460 |  |  | 30,627 |
Impairment and other charges | 5,371 |  |  | 146 |
Benefit for deferred income taxes | 55 |  |  | 229 |
Equity-based compensation expense | 784 |  |  | 2,165 |
Provision for doubtful accounts | 1,380 |  |  | 627 |
Amortization and expense of financing costs | 569 |  |  | 1,292 |
CCLP Series A Preferred Unit distributions and adjustments | — |  |  | 2,159 |
Warrants fair value adjustment | (337 | ) |  | 407 |
Contingent consideration liability fair value adjustment | — |  |  | (400 | )
Gain on sale of assets | (833 | ) |  | (201 | )
Changes in operating assets and liabilities: |  |  |  |  |
Accounts receivable | 3,601 |  |  | 2,353 |
Inventories | (12,414 | ) |  | (15,809 | )
Prepaid expenses and other current assets | (2,442 | ) |  | (3,222 | )
Trade accounts payable and accrued expenses | 8,742 |  |  | 6,638 |
Other | (1,384 | ) |  | (499 | )
Net cash provided by operating activities | 22,176 |  |  | 7,412 |
Investing activities: |  |  |  |  |
Purchases of property, plant, and equipment, net | (12,390 | ) |  | (32,409 | )
Proceeds on sale of property, plant, and equipment | 1,425 |  |  | 364 |
Other investing activities | 350 |  |  | 319 |
Net cash used in investing activities | (10,615 | ) |  | (31,726 | )
Financing activities: |  |  |  |  |
Proceeds from long-term debt | 56,512 |  |  | 66,000 |
Principal payments on long-term debt | (54,511 | ) |  | (35,451 | )
CCLP distributions | (309 | ) |  | (307 | )
Redemptions of CCLP Series A Preferred | — |  |  | (8,346 | )
Tax remittances on equity based compensation | (319 | ) |  | (429 | )
Debt issuance costs and other financing activities | (235 | ) |  | (155 | )
Net cash provided by financing activities | 1,138 |  |  | 21,312 |
Effect of exchange rate changes on cash | (940 | ) |  | (167 | )
Increase (decrease) in cash and cash equivalents | 11,759 |  |  | (3,169 | )
Cash and cash equivalents and restricted cash at beginning of period | 17,768 |  |  | 40,102 |
Cash and cash equivalents and restricted cash at end of period | $ | 29,527 |  |  | $ | 36,933 |
Supplemental cash flow information: |  |  |  |
Interest paid | $ | 15,421 |  |  | $ | 15,544 |
Income taxes paid | 1,479 |  |  | 1,644 |

See Notes to Consolidated Financial Statements
6

Table of Contents
TETRA Technologies, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
NOTE 1 – ORGANIZATION, BASIS OF PRESENTATION, AND SIGNIFICANT ACCOUNTING POLICIES
Organization
We are a geographically diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing and offshore rig cooling services, and compression services and equipment. We were incorporated in Delaware in 1981. We are composed of three divisions – Completion Fluids & Products, Water & Flowback Services, and Compression. Unless the context requires otherwise, when we refer to “we,” “us,” and “our,” we are describing TETRA Technologies, Inc. and its consolidated subsidiaries on a consolidated basis.
Presentation
Our unaudited consolidated financial statements include the accounts of our wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The information furnished reflects all normal recurring adjustments, which are, in the opinion of management, necessary to provide a fair statement of the results for the interim periods. Operating results for the period ended March 31, 2020 are not necessarily indicative of results that may be expected for the twelve months ended December 31, 2020.
We consolidate the financial statements of our CSI Compressco LP subsidiary ("CCLP") as part of our Compression Division, as we determined that CCLP is a variable interest entity and we are the primary beneficiary. We control the financial interests of CCLP and have the ability to direct the activities of CCLP that most significantly impact its economic performance through our ownership of its general partner. The share of CCLP net assets and earnings that is not owned by us is presented as noncontrolling interest in our consolidated financial statements. Our cash flows from our investment in CCLP are limited to the quarterly distributions we receive on our CCLP common units and general partner interest (including incentive distribution rights) and the amounts collected for services we perform on behalf of CCLP, as TETRA's capital structure and CCLP's capital structure are separate, and do not include cross default provisions, cross collateralization provisions, or cross guarantees.
The accompanying unaudited consolidated financial statements have been prepared in accordance with Rule 10-01 of Regulation S-X for interim financial statements required to be filed with the U.S. Securities and Exchange Commission ("SEC") and do not include all information and footnotes required by U.S. generally accepted accounting principles ("U.S. GAAP") for complete financial statements. These financial statements should be read in conjunction with the financial statements for the year ended December 31, 2019 and notes thereto included in our Annual Report on Form 10-K, which we filed with the SEC on March 16, 2020.
Significant Accounting Policies
Our significant accounting policies are described in the notes to our consolidated financial statements for the year ended December 31, 2019 included in our Annual Report on Form 10-K. There have been no significant changes in our accounting policies or the application thereof during the first quarter of 2020.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues, expenses, and impairments during the reporting period. Actual results could differ from those estimates, and such differences could be material.
Reclassifications
Certain previously reported financial information has been reclassified to conform to the current year's presentation. The impact of such reclassifications was not significant to the prior year's overall presentation.
7

Table of Contents
Impairments and Other Charges
Impairments of long-lived assets, including identified intangible assets, are determined periodically when indicators of impairment are present. If such indicators are present, the determination of the amount of impairment is based on our judgment as to the future undiscounted operating cash flows to be generated from the relevant assets throughout their remaining estimated useful lives. If these undiscounted cash flows are less than the carrying amount of the related assets, an impairment is recognized for the excess of the carrying value over fair value. Fair value of intangible assets is generally determined using the discounted present value of future cash flows using discount rates commensurate with the risks inherent with the specific assets. Assets held for disposal are recorded at the lower of carrying value or estimated fair value less estimated selling costs. See Note 3 - "Impairments and Other Charges" for additional discussion of recorded impairments.
Revenue Recognition
Performance Obligations. Revenue is generally recognized when we transfer control of our products or services to our customers. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or providing services to our customers. We receive cash equal to the invoice price for most sales of product and services and payment terms typically range from 30 to 60 days from the date we invoice our customer. Since the period between when we deliver products or services and when the customer pays for such products or services is not expected to exceed one year, we have elected not to calculate or disclose a financing component for our customer contracts.
Depending on the terms of the arrangement, we may also defer the recognition of revenue for a portion of the consideration received because we have to satisfy a future performance obligation. For example, consideration received from customers during the fabrication of new compressor packages is typically deferred until control of the compressor package is transferred to our customer.
For any arrangements with multiple performance obligations, we use management's estimated selling price to determine the stand-alone selling price for separate performance obligations. For revenue associated with mobilization of service equipment as part of a service contract arrangement, such revenue, if significant, is deferred and amortized over the estimated service period.
Product Sales. Product sales revenues are generally recognized when we ship products from our facility to our customer. The product sales for our Completion Fluids & Products Division consist primarily of clear brine fluids ("CBFs"), additives, and associated manufactured products. Product sales for our Water & Flowback Services Division are typically attributed to specific performance obligations within certain production testing service arrangements. Parts and equipment sales comprise the product sales for the Compression Division.
Services. Service revenues represent revenue recognized over time, as our customer arrangements typically provide agreed upon day-rates (monthly service rates for compression services) and we recognize service revenue based upon the number of days services have been performed. Service revenue recognized over time is associated with a majority of our Water & Flowback Services Division arrangements, compression service and aftermarket service contracts within our Compression Division, and a small portion of Completion Fluids & Products Division revenue that is associated with completion fluid service arrangements. With the exception of the initial terms of the compression services contracts for medium- and high-horsepower compressor packages of our Compression Division, our customer contracts are generally for terms of one year or less. The majority of the service arrangements in the Water & Flowback Services Division are for a period of 90 days or less.
Sales taxes, value added taxes, and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost for freight and shipping costs as part of cost of product sales when control over our products (i.e. delivery) has transferred to the customer.
Use of Estimates. In recognizing revenue for variable consideration arrangements, the amount of variable consideration recognized is limited so that it is probable that significant amounts of revenues will not be reversed in future periods when the uncertainty is resolved. For products returned by the customer, we estimate the expected returns based on an analysis of historical experience. For volume discounts earned by the customer, we estimate the discount (if any) based on our estimate of the total expected volume of products sold or services to be provided to the customer during the discount period. In certain contracts for the sale of CBFs, we may agree to issue credits
8

Table of Contents
for the repurchase of reclaimable used fluids from certain customers at an agreed price that is based on the condition of the fluids.
Contract Assets and Liabilities. We consider contract assets to be trade accounts receivable when we have an unconditional right to consideration and only the passage of time is required before payment is due. In certain instances, particularly those requiring customer specific documentation prior to invoicing, our invoicing of the customer is delayed until certain documentation requirements are met. In those cases, we recognize a contract asset rather than a billed trade accounts receivable until we are able to invoice the customer. Contract assets, along with billed trade accounts receivable, are included in trade accounts receivable in our consolidated balance sheets.
We classify contract liabilities as unearned income in our consolidated balance sheets. Such deferred revenue typically results from advance payments received on orders for new compressor equipment prior to the time such equipment is completed and transferred to the customer in accordance with the customer contract. New equipment sales orders generally take less than twelve months to build and deliver.
Bill-and-Hold Arrangements. We design and fabricate compressor packages based on our customer’s specifications. In some cases, the customer will request us to hold the equipment, upon completion of the unit, until the job site is ready to receive the equipment. When this occurs, we along with the customer sign a bill-and-hold agreement, which outlines that the customer has title to the equipment, the equipment is ready for delivery, we cannot use the equipment or direct it to another customer, and we have a present right to payment. When those criteria have been met and the agreement is executed, we recognize the revenue on the equipment because control of the equipment has passed to our customer and our performance obligations are complete. Entering into these arrangements is something we have done as a courtesy for certain customers for many years. The equipment subject to the bill-and-hold agreements has generally been invoiced and paid for through progressive billings such that at the time the bill-and-hold agreement is executed, the majority of the contractual cash obligation of the customer has been received by us.
Operating Costs
Cost of product sales includes direct and indirect costs of manufacturing and producing our products, including raw materials, fuel, utilities, labor, overhead, repairs and maintenance, materials, services, transportation, warehousing, equipment rentals, insurance, and certain taxes. Cost of services includes operating expenses we incur in delivering our services, including labor, equipment rental, fuel, repair and maintenance, transportation, overhead, insurance, and certain taxes. We include in product sales revenues the reimbursements we receive from customers for shipping and handling costs. Shipping and handling costs are included in cost of product sales. Amounts we incur for “out-of-pocket” expenses in the delivery of our services are recorded as cost of services. Reimbursements for “out-of-pocket” expenses we incur in the delivery of our services are recorded as service revenues. Depreciation, amortization, and accretion includes depreciation expense for all of our facilities, equipment and vehicles, amortization expense on our intangible assets, and accretion expense related to our decommissioning and other asset retirement obligations.
We include in general and administrative expense all costs not identifiable to our specific product or service operations, including divisional and general corporate overhead, professional services, corporate office costs, sales and marketing expenses, insurance, and certain taxes.
Foreign Currency Translation
We have designated the euro, the British pound, the Norwegian krone, the Canadian dollar, the Brazilian real, and the Mexican peso as the functional currencies for our operations in Finland and Sweden, the United Kingdom, Norway, Canada, Brazil, and certain of our operations in Mexico, respectively. The U.S. dollar is the designated functional currency for all of our other foreign operations. The cumulative translation effects of translating the applicable accounts from the functional currencies into the U.S. dollar at current exchange rates are included as a separate component of equity. Foreign currency exchange (gains) and losses are included in other (income) expense, net and totaled $1.9 million during the three months ended March 31, 2020, and $(1.2) million during the three months ended March 31, 2019, respectively.
9

Table of Contents
Fair Value Measurements
We utilize fair value measurements to account for certain items and account balances within our consolidated financial statements. Fair value measurements are utilized on a recurring basis in the determination of the carrying values of certain liabilities, including the liabilities for the warrants to purchase 11.2 million shares of our common stock (the "Warrants") and our foreign currency derivative contracts. Refer to Note 9 - "Fair Value Measurements" for further discussion.
Fair value measurements are also utilized on a nonrecurring basis in certain circumstances, such as in the allocation of purchase consideration for acquisition transactions to the assets and liabilities acquired, including intangible assets and goodwill (a Level 3 fair value measurement), the initial recording of our asset retirement obligations, and for the impairment of long-lived assets, including goodwill (a Level 3 fair value measurement).
New Accounting Pronouncements
Standards adopted in 2020
In August 2018, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2018-15, "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract." ASU 2018-15 clarifies the accounting for implementation costs in cloud computing arrangements. ASU 2018-15 is effective for interim and annual reporting periods beginning after December 15, 2019, and early adoption is permitted. The adoption of this standard did not have a material impact on our consolidated financial statements.
Standards not yet adopted
In June 2016, the FASB issued ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments." ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses on financial instruments not accounted for at fair value through net income. The provisions require credit impairments to be measured over the contractual life of an asset and developed with consideration for past events, current conditions, and forecasts of future economic information. Credit impairment will be accounted for as an allowance for credit losses deducted from the amortized cost basis at each reporting date. We are continuing to work through our implementation plan which includes evaluating the impact on our allowance for doubtful accounts methodology, identifying new reporting requirements, and implementing changes to business processes, systems, and controls to support adoption of the standard. Upon adoption, the allowance for doubtful accounts is expected to increase with an offsetting adjustment to retained earnings. Updates at each reporting date after initial adoption will be recorded through selling, general, and administrative expense. ASU 2016-13 has an effective date of the first quarter of fiscal 2023. We continue to assess the potential effects of these changes to our consolidated financial statements.
In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes." ASU 2019-12 simplifies the accounting for income taxes by eliminating certain exceptions related to intraperiod tax allocation, interim period income tax calculation methodology, and the recognition of deferred tax liabilities for outside basis differences. It also simplifies certain aspects of accounting for franchise taxes and clarifies the accounting for transactions that results in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for us the first quarter of fiscal 2021. We continue to assess the potential effects of these changes to our consolidated financial statements.
In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848)”, which provides optional expedients and exceptions for applying US GAAP to contracts, hedging relationships, and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or by another reference rate expected to be discontinued. The amendments are effective for all entities as of March 12, 2020 through December 31, 2022. We are currently evaluating the impacts of the provisions of ASU 2020-04 on our consolidated financial statements.
10

Table of Contents
NOTE 2 – REVENUE FROM CONTRACTS WITH CUSTOMERS
As of March 31, 2020, we had $56.7 million of remaining contractual performance obligations for compression services. As a practical expedient, this amount does not reflect revenue for compression service contracts whose original expected duration is less than twelve months and does not consider the effects of the time value of money. Expected revenue to be recognized in the future as of March 31, 2020 for completion of performance obligations of compression service contracts are as follows:

| 2020 |  | 2021 |  | 2022 |  | 2023 |  | 2024 |  | Total
| (In Thousands)
Compression service contracts remaining performance obligations | $ | 38,720 |  |  | $ | 15,941 |  |  | $ | 2,026 |  |  | $ | 54 |  |  | $ | — |  |  | $ | 56,741 |

For sales of CBFs where we have agreed to issue credits for the repurchase of reclaimable used fluids at an agreed price based on the condition of the fluid upon return, we adjust the revenue recognized in the period of shipment by an estimated amount, based on historical experience, of the credit expected to be issued. As of March 31, 2020, the amount of remaining credits expected to be issued for the repurchase of reclaimable used fluids was $5.6 million recorded in inventory (right of return asset) and either accounts payable or as a reduction to accounts receivable. T here were no material differences between amounts recognized during the three month period ended March 31, 2020, compared to estimates made in a prior period from these variable consideration arrangements.
Our contract asset balances, primarily associated with customer documentation requirements, were $33.3 million and $34.9 million as of March 31, 2020 and December 31, 2019, respectively. Contract assets, along with billed trade accounts receivable, are included in trade accounts receivable in our consolidated balance sheets.
Collections primarily associated with progressive billings to customers for the construction of compression equipment is included in unearned income in the consolidated balance sheets. The following table reflects the changes in unearned income in our consolidated balance sheets for the periods indicated:

| Three Months Ended March 31,
| 2020 |  | 2019
| (In Thousands)
Unearned Income, beginning of period | $ | 9,678 |  |  | $ | 25,333 |
Additional unearned income | 23,869 |  |  | 49,363 |
Revenue recognized | (5,767 | ) |  | (24,858 | )
Unearned income, end of period | $ | 27,780 |  |  | $ | 49,838 |

During the three month period ended March 31, 2020, we recognized product sales revenue of $2.9 million from unearned income that was deferred as of December 31, 2019. During the three months ended March 31, 2019, we recognized product sales revenue of $11.0 million from unearned income that was deferred as of December 31, 2018.
As of March 31, 2020, contract costs were immaterial.
11

Table of Contents
We disaggregate revenue from contracts with customers into Product Sales and Services within each segment, as noted in our three reportable segments in Note 11. In addition, we disaggregate revenue from contracts with customers by geography based on the following table below.

| Three Months Ended March 31,
| 2020 |  | 2019
| (In Thousands)
Completion Fluids & Products |  |  |
U.S. | $ | 37,958 |  |  | $ | 31,606 |
International | 37,279 |  |  | 29,975 |
| 75,237 |  |  | 61,581 |
Water & Flowback Services |  |  |
U.S. | 54,384 |  |  | 73,199 |
International | 3,083 |  |  | 5,479 |
| 57,467 |  |  | 78,678 |
Compression |  |  |
U.S. | 80,599 |  |  | 93,517 |
International | 9,639 |  |  | 9,952 |
| 90,238 |  |  | 103,469 |
Total Revenue |  |  |
U.S. | 172,941 |  |  | 198,322 |
International | 50,001 |  |  | 45,406 |
| $ | 222,942 |  |  | $ | 243,728 |

NOTE 3 – IMPAIRMENTS AND OTHER CHARGES
Impairments of Long-Lived Assets
During the first quarter of 2020, the COVID-19 pandemic and decline in oil prices had a significant impact on our customers and industry. We started to see our customers revise their capital budgets downwards and adjust their operations accordingly, which led to a decline in orders for new compression equipment to be fabricated and sold to third parties, among other impacts. We concluded these events were indicators of impairment for all asset groups within our Compression Division and certain asset groups within our Completion Fluids & Products Division. As a result, we performed recoverability analyses on the relevant asset groups within these divisions. Based upon these recoverability analyses, we determined that the carrying values of our Midland manufacturing facility and related new unit sales inventory in our Compression Division exceeded their respective fair values. Therefore, we recorded impairments of approximately $5.4 million during the first quarter of 2020 related to these assets. Fair value was estimated based on a market approach. No other recoverability analysis performed indicated an impairment as of March 31, 2020. Given the dynamic nature of the events beginning in the first quarter of 2020, we are not able to reasonably estimate how long our operations will be adversely impacted and the full extent these events will have on our operations. As a result, we could have indicators of impairment again in future periods resulting in additional asset impairments.
NOTE 4 – INVENTORIES
Components of inventories as of March 31, 2020 and December 31, 2019 are as follows:

| March 31, 2020 |  | December 31, 2019
| (In Thousands)
Finished goods | $ | 67,824 |  |  | $ | 70,135 |
Raw materials | 3,886 |  |  | 4,125 |
Parts and supplies | 38,859 |  |  | 47,793 |
Work in progress | 31,547 |  |  | 14,457 |
Total inventories | $ | 142,116 |  |  | $ | 136,510 |

12

Table of Contents
Finished goods inventories include newly manufactured clear brine fluids as well as used brines that are repurchased from certain customers for recycling. Work in progress inventory consists primarily of new compressor packages located at our Compression Division manufacturing facility in Midland, Texas.
NOTE 5 – LEASES
We have operating leases for some of our transportation equipment, office space, warehouse space, operating locations, and machinery and equipment. We have finance leases for certain storage tanks and equipment rentals. These finance leases are not material to our financial statements. Our leases have remaining lease terms ranging from 1 to 16 years. Some of our leases have options to extend for various periods, while some have termination options with prior notice of generally 30 days or six months. The office space, warehouse space, operating location leases, and machinery and equipment leases generally require us to pay all maintenance and insurance costs. During the fourth quarter of 2019, CCLP entered into a lease agreement commitment for 14 compressor packages. The leases are for an initial term of seven years and commence upon the completion of the equipment fabrication. During the first quarter, CCLP took delivery of eight compressor packages. We anticipate taking delivery of the remaining six compressor packages when the compression units are completed, which is expected to occur during the second quarter of 2020. We have no other lease commitments that have not yet commenced that create significant rights and obligations. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Variable rent expense was not material.
Our corporate headquarters facility located in The Woodlands, Texas, was sold on December 31, 2012, pursuant to a sale and leaseback transaction. As a condition to the consummation of the purchase and sale of the facility, the parties entered into a lease agreement for the facility having an initial lease term of 15 years, which is classified as an operating lease. Under the terms of the lease agreement, we have the ability to extend the lease for five successive five-year periods at base rental rates to be determined at the time of each extension.
Components of lease expense, included in either cost of revenues or general and administrative expense based on the use of the underlying asset, are as follows (inclusive of lease expense for leases not included on our consolidated balance sheet based on our accounting policy election to exclude leases with a term of 12 months or less):

| Three Months Ended March 31,
| 2020 |  | 2019
| (In Thousands)
Operating lease expense | $ | 5,148 |  |  | $ | 5,044 |
Short-term lease expense | 9,430 |  |  | 11,161 |
Total lease expense | $ | 14,578 |  |  | $ | 16,205 |

Supplemental cash flow information:

|  | Three Months Ended March 31,
|  | 2020 |  | 2019
|  | (In Thousands)
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |
Operating cash flows - operating leases |  | $ | 5,949 |  |  | $ | 4,657 |
Right-of-use assets obtained in exchange for lease obligations: |  |  |  |
Operating leases |  | $ | 11,844 |  |  | $ | 3,257 |

13

Table of Contents
Supplemental balance sheet information:

| March 31, 2020 |  | December 31, 2019
| (In Thousands)
Operating leases: |  |  |
Operating lease right-of-use assets | $ | 75,344 |  |  | $ | 68,131 |
Accrued liabilities and other | $ | 16,782 |  |  | $ | 15,850 |
Operating lease liabilities | 59,845 |  |  | 53,919 |
Total operating lease liabilities | $ | 76,627 |  |  | $ | 69,769 |

Additional operating lease information:

| March 31, 2020 |  | December 31, 2019
Weighted average remaining lease term: |  |  |
Operating leases | 6.37 Years |  |  | 6.43 Years |
Weighted average discount rate: |  |  |
Operating leases | 9.43 | % |  | 9.46 | %

Future minimum lease payments by year and in the aggregate, under non-cancellable operating leases with terms in excess of one year consist of the following at March 31, 2020:

|  | Operating Leases
| (In Thousands)
Remainder of 2020 |  | $ | 19,961 |
2021 |  | 22,092 |
2022 |  | 18,422 |
2023 |  | 14,776 |
2024 |  | 12,372 |
Thereafter |  | 30,268 |
Total lease payments |  | 117,891 |
Less imputed interest |  | (41,264 | )
Total lease liabilities |  | $ | 76,627 |

At March 31, 2020, future minimum rental receipts under a non-cancellable sublease for office space in one of our locations totaled $6.1 million. For the three months ended March 31, 2020, we recognized sublease income of $0.3 million.
14

Table of Contents
NOTE 6 – LONG-TERM DEBT AND OTHER BORROWINGS
We believe our capital structure, excluding CCLP, ("TETRA") and CCLP's capital structure should be considered separately, as there are no cross default provisions, cross collateralization provisions, or cross guarantees between CCLP's debt and TETRA's debt.
Consolidated long-term debt as of March 31, 2020 and December 31, 2019, consists of the following:

|  | March 31, 2020 |  | December 31, 2019
|  | (In Thousands)
TETRA | Scheduled Maturity |  |  |
Asset-based credit agreement (presented net of unamortized deferred financing costs of $1.3 million as of March 31, 2020 and $1.0 million as of December 31, 2019) | September 2023 | $ | 2,246 |  |  | $ | — |
Term credit agreement (presented net of the unamortized discount of $6.2 million as of March 31, 2020 and $6.4 million as of December 31, 2019 and net of unamortized deferred financing costs of $9.2 million as of March 31, 2020 and $9.5 million as of December 31, 2019) | September 2025 | 205,167 |  |  | 204,633 |
TETRA total debt |  | 207,413 |  |  | 204,633 |
Less current portion |  | — |  |  | — |
TETRA total long-term debt |  | $ | 207,413 |  |  | $ | 204,633 |
CCLP |  |  |  |
CCLP asset-based credit agreement (presented net of unamortized deferred financing costs of $0.8 million as of March 31, 2020 and $0.9 million of December 31, 2019) | June 2023 | 2,184 |  |  | 2,622 |
CCLP 7.25% Senior Notes (presented net of the unamortized discount of $1.5 million as of March 31, 2020 and $1.7 million as of December 31, 2019 and net of unamortized deferred financing costs of $2.6 million as of March 31, 2020 and $2.8 million as of December 31, 2019) | August 2022 | 291,863 |  |  | 291,444 |
CCLP 7.50% Senior Secured Notes (presented net of unamortized deferred financing costs of $5.6 million as of March 31, 2020 and $5.8 million as of December 31, 2019) | April 2025 | 344,382 |  |  | 344,172 |
CCLP total debt |  | 638,429 |  |  | 638,238 |
Less current portion |  | — |  |  | — |
CCLP total long-term debt |  | $ | 638,429 |  |  | $ | 638,238 |
Consolidated total long-term debt |  | $ | 845,842 |  |  | $ | 842,871 |

As of March 31, 2020, TETRA had a $3.5 million outstanding balance and $7.9 million in letters of credit against its asset-based credit agreement ("ABL Credit Agreement"). As of March 31, 2020, subject to compliance with the covenants, borrowing base, and other provisions of the ABL Credit Agreement that may limit borrowings, TETRA had an availability of $40.8 million under this agreement. There was a $3.0 million balance outstanding and $3.0 million in letters of credit against the CCLP asset-based credit agreement ("CCLP Credit Agreement") as of March 31, 2020. As of March 31, 2020, and subject to compliance with the covenants, borrowing base, and other provisions of the CCLP Credit Agreement that may limit borrowings, CCLP had availability of $20.4 million.
TETRA and CCLP credit and senior note agreements contain certain affirmative and negative covenants, including covenants that restrict the ability to pay dividends or other restricted payments. TETRA and CCLP are both in compliance with all covenants of their respective credit and senior note agreements as of March 31, 2020.
15

Table of Contents
NOTE 7 – DISCONTINUED OPERATIONS
On March 1, 2018, we closed a series of related transactions that resulted in the disposition of our Offshore Division. As a result, we have accounted for our Offshore Division, consisting of our Offshore Services and Maritech segments, as discontinued operations. See Note 8 - "Commitments and Contingencies" for further discussion. A summary of financial information related to our discontinued operations is as follows:
Reconciliation of the Line Items Constituting Pretax Loss from Discontinued Operations to the After-Tax Loss from Discontinued Operations
(in thousands)

| Three Months Ended March 31, 2020 |  | Three Months Ended March 31, 2019
| Offshore Services |  | Maritech |  | Total |  | Offshore Services |  | Maritech |  | Total
Major classes of line items constituting pretax loss from discontinued operations |  |  |  |  |  |  |  |  |  |  |
Revenue | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Cost of revenues | (60 | ) |  | — |  |  | (60 | ) |  | 22 |  |  | — |  |  | 22 |
Depreciation, amortization, and accretion | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
General and administrative expense | 205 |  |  | — |  |  | 205 |  |  | 404 |  |  | — |  |  | 404 |
Other (income) expense, net | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Pretax loss from discontinued operations | (145 | ) |  | — |  |  | (145 | ) |  | (426 | ) |  | — |  |  | (426 | )
Pretax loss on disposal of discontinued operations |  |  |  |  | — |  |  |  |  |  |  | — |
Total pretax loss from discontinued operations |  |  |  |  | (145 | ) |  |  |  |  |  | (426 | )
Income tax benefit |  |  |  |  | — |  |  |  |  |  |  | — |
Total loss from discontinued operations |  |  |  |  | $ | (145 | ) |  |  |  |  |  | $ | (426 | )

Reconciliation of Major Classes of Assets and Liabilities of the Discontinued Operations to Amounts Presented Separately in the Statement of Financial Position
(in thousands)

| March 31, 2020 |  | December 31, 2019
| Offshore Services |  | Maritech |  | Total |  | Offshore Services |  | Maritech |  | Total
Carrying amounts of major classes of assets included as part of discontinued operations |  |  |  |  |  |  |  |  |  |  |
Trade receivables | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Other current assets | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Assets of discontinued operations | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Carrying amounts of major classes of liabilities included as part of discontinued operations |  |  |  |  |  |  |  |  |  |  |
Trade payables | $ | 1,303 |  |  | $ | — |  |  | $ | 1,303 |  |  | $ | 1,233 |  |  | $ | — |  |  | $ | 1,233 |
Accrued liabilities | 480 |  |  | 228 |  |  | 708 |  |  | 745 |  |  | 120 |  |  | 865 |
Liabilities of discontinued operations | $ | 1,783 |  |  | $ | 228 |  |  | $ | 2,011 |  |  | $ | 1,978 |  |  | $ | 120 |  |  | $ | 2,098 |

NOTE 8 – COMMITMENTS AND CONTINGENCIES
Litigation
We are named defendants in several lawsuits and respondents in certain governmental proceedings arising in the ordinary course of business. While the outcome of lawsuits or other proceedings against us cannot be predicted with certainty, management does not consider it reasonably possible that a loss resulting from such lawsuits or other proceedings in excess of any amounts accrued has been incurred that is expected to have a material adverse impact on our financial condition, results of operations, or liquidity.
16

Table of Contents
Contingencies of Discontinued Operations
In early 2018, we closed the Maritech Asset Purchase and Sale Agreement with Orinoco Natural Resources, LLC ("Orinoco") that provided for the purchase by Orinoco of Maritech's remaining oil and gas properties and related assets. Shortly thereafter, we closed the Maritech Membership Interest Purchase and Sale Agreement with Orinoco that provided for the purchase by Orinoco of all of the outstanding membership interests in Maritech. As a result of these transactions, we have effectively exited the business of our former Maritech segment.
Under the Maritech Asset Purchase and Sale Agreement, Orinoco assumed all of Maritech’s decommissioning liabilities related to the leases sold to Orinoco (the “Orinoco Lease Liabilities”) and, under the Maritech Membership Interest Purchase and Sale Agreement, Orinoco assumed all other liabilities of Maritech, including the decommissioning liabilities associated with the oil and gas properties previously sold by Maritech (the “Legacy Liabilities”), subject to certain limited exceptions unrelated to the decommissioning liabilities. To the extent that Maritech or Orinoco fails to satisfy decommissioning liabilities associated with any of the Orinoco Lease Liabilities or the Legacy Liabilities, we may be required to satisfy such liabilities under third party indemnity agreements and corporate guarantees that we previously provided to the US Department of the Interior and other parties, respectively.
Pursuant to a Bonding Agreement entered into as part of these transactions (the "Bonding Agreement"), Orinoco provided non-revocable performance bonds in an aggregate amount of $46.8 million to cover the performance by Orinoco and Maritech of the asset retirement obligations of Maritech (the “Initial Bonds”) and agreed to replace, within 90 days following the closing, the Initial Bonds with other non-revocable performance bonds, meeting certain requirements, in the aggregate sum of $47.0 million (collectively, the “Interim Replacement Bonds”). Orinoco further agreed to replace, within 180 days following the closing, the Interim Replacement Bonds with a maximum of three non-revocable performance bonds in the aggregate sum of $47.0 million, meeting certain requirements (the “Final Bonds”). Among the other requirements of the Final Bonds was that they must provide coverage for all of the asset retirement obligations of Maritech instead of only relating to specific properties. In the event Orinoco did not provide the Interim Replacement Bonds or the Final Bonds, Orinoco was required to make certain cash escrow payments to us.
The payment obligations of Orinoco under the Bonding Agreement were guaranteed by Thomas M. Clarke and Ana M. Clarke pursuant to a separate guaranty agreement (the “Clarke Bonding Guaranty Agreement”). Orinoco has not delivered such replacement bonds and neither it nor the Clarkes has made any of the agreed upon cash escrow payments and we filed a lawsuit against Orinoco and the Clarkes to enforce the terms of the Bonding Agreement and the Clarke Bonding Guaranty Agreement. A summary judgment was initially granted in favor of Orinoco and the Clarkes which dismissed our claims against Orinoco under the Bonding Agreement and against the Clarkes under the Clarke Bonding Guaranty Agreement. We filed an appeal and also asked the trial court to grant a new trial on the summary judgment or to modify the judgment because we believe this judgment should not have been granted. On November 5, 2019, the trial court signed an order granting our motion for new trial and vacating the prior order granting summary judgment for Orinoco and the Clarkes. The parties are awaiting direction from the court on a new scheduling order and/or trial setting. The Initial Bonds, which are non-revocable, remain in effect.
If we become liable in the future for any decommissioning liability associated with any property covered by either an Initial Bond or an Interim Replacement Bond while such bonds are outstanding and the payment made to us under such bond is not sufficient to satisfy such liability, the Bonding Agreement provides that Orinoco will pay us an amount equal to such deficiency and if Orinoco fails to pay any such amount, such amount must be paid by the Clarkes under the Clarke Bonding Guaranty Agreement. However, if the Final Bonds or the full amount of the escrowed cash have been provided, neither Orinoco nor the Clarkes would be liable to pay us for any such deficiency. Our financial condition and results of operations may be negatively affected if Orinoco is unable to cover any such deficiency or if we become liable for a significant portion of the decommissioning liabilities.
In early 2018, we also closed the sale of our Offshore Division to Epic Companies, LLC (“Epic Companies,” formerly known as Epic Offshore Specialty, LLC). Part of the consideration we received was a promissory note of Epic Companies in the original principal amount of $7.5 million (the “Epic Promissory Note”) payable to us in full, together with interest at a rate of 1.52% per annum, on December 31, 2019, along with a personal guaranty agreement from Thomas M. Clarke and Ana M. Clarke guaranteeing the payment obligations of Epic Companies pursuant to the Epic Promissory Note (the “Clarke Promissory Note Guaranty Agreement”). Additionally, pursuant to the Equity Interest Purchase Agreement (the “Offshore Services Purchase Agreement”) and other agreements with Epic Companies, certain other amounts relating to the Offshore Division totaling approximately $1.5 million were
17

Table of Contents
payable to us. At the end of August 2019, Epic Companies filed for bankruptcy. We recorded a reserve of $7.5 million for the full amount of the promissory note, including accrued interest, and the certain other receivables in the amount of $1.5 million during the quarter ended September 30, 2019. The Epic Promissory Note became due on December 31, 2019 but neither Epic nor the Clarkes made the required payment. Upon the default by Epic and the Clarkes, we filed a lawsuit against the Clarkes on January 15, 2020 in Montgomery County, Texas for breach of the Clarke Promissory Note Guaranty Agreement, seeking the amounts due under the Epic Promissory Note and related interest, as well as attorneys’ fees and expenses. The Clarkes each filed an answer and counterclaims for fraud and negligent misrepresentation and seek monetary damages in excess of $1 million, punitive damages, and attorneys’ fees. We will vigorously prosecute our claim and defend against the claims by the Clarkes.
NOTE 9 – FAIR VALUE MEASUREMENTS
Financial Instruments
Warrants
The Warrants are valued using a Black Scholes option valuation model that includes implied volatility of the trading price (a Level 3 fair value measurement).
Derivative Contracts
We and CCLP each enter into short term foreign currency forward derivative contracts with third parties as part of a program designed to mitigate the currency exchange rate risk exposure on selected transactions of certain foreign subsidiaries. As of March 31, 2020, we and CCLP had the following foreign currency derivative contracts outstanding relating to portions of our foreign operations:

Derivative Contracts |  | US Dollar Notional Amount |  | Traded Exchange Rate |  | Settlement Date
|  | (In Thousands) |  |  |  |
Forward purchase Euro |  | $ | 8,167 |  |  | 1.08 |  | 4/21/2020
Forward purchase Euro |  | 10,497 |  |  | 1.10 |  | 4/21/2020
Forward purchase pounds sterling |  | 9,400 |  |  | 1.17 |  | 4/21/2020
Forward sale pounds sterling |  | 500 |  |  | 1.18 |  | 4/21/2020
Forward sale pounds sterling |  | 1,875 |  |  | 1.17 |  | 4/21/2020
Forward sale Norwegian krone |  | 1,000 |  |  | 11.76 |  | 4/21/2020
Forward purchase Norwegian krone |  | 4,300 |  |  | 11.36 |  | 4/21/2020
Forward sale Mexican peso |  | 4,974 |  |  | 24.40 |  | 4/21/2020

Derivative Contracts |  | British Pound Notional Amount |  | Traded Exchange Rate |  | Settlement Date
|  | (In Thousands) |  |  |  |
Forward purchase Euro |  | £ | 3,445 |  |  | 0.92 |  | 4/21/2020

Derivative Contracts |  | Swedish Krona Notional Amount |  | Traded Exchange Rate |  | Settlement Date
|  | (In Thousands) |  |  |  |
Forward purchase Euro |  |  | 210 | kr |  | 10.90 |  | 4/6/2020
Forward purchase Euro |  |  | 66,690 | kr |  | 10.91 |  | 4/6/2020
Forward purchase Euro |  |  | 2,400 | kr |  | 11.24 |  | 4/21/2020

Under this program, we and CCLP may enter into similar derivative contracts from time to time. Although contracts pursuant to this program will serve as an economic hedge of the cash flow of our currency exchange risk exposure, they are not formally designated as hedge contracts or qualify for hedge accounting treatment. Accordingly, any change in the fair value of these derivative contracts during a period will be included in the determination of earnings for that period.
The fair values of foreign currency derivative contracts are based on quoted market values (a Level 2 fair value measurement). The fair values of our and CCLP's foreign currency derivative contracts as of March 31, 2020
18

Table of Contents
and December 31, 2019, are as follows:

Foreign currency derivative contracts | Balance Sheet Location |  | Fair Value at March 31, 2020 |  | Fair Value at December 31, 2019
|  |  |  | (In Thousands)
Forward purchase contracts |  | Current assets |  | $ | 1,160 |  |  | $ | 86 |
Forward sale contracts |  | Current liabilities |  | (433 | ) |  | (53 | )
Forward purchase contracts |  | Current liabilities |  | (181 | ) |  | (3 | )
Net asset (liability) |  |  |  | $ | 546 |  |  | $ | 30 |

None of our foreign currency derivative contracts contain credit risk related contingent features that would require us to post assets or collateral for contracts that are classified as liabilities. During the three months ended March 31, 2020 and March 31, 2019, we recognized $(1.0) million and $0.6 million of net (gains) losses, respectively, reflected in other (income) expense, net, associated with our foreign currency derivative program.
During the first quarter of 2020, we recorded impairments of approximately $5.4 million, reflecting the decreased fair value for certain assets. The fair values used in these impairment calculations were estimated based on a market approach, which is based on significant unobservable inputs (Level 3) in accordance with the fair value hierarchy.
Recurring and nonrecurring fair value measurements by valuation hierarchy as of March 31, 2020 and December 31, 2019, are as follows:

|  |  | Fair Value Measurements Using
| Total as of |  | Quoted Prices in Active Markets for Identical Assets or Liabilities |  | Significant Other Observable Inputs |  | Significant Unobservable Inputs
Description | March 31, 2020 |  | (Level 1) |  | (Level 2) |  | (Level 3)
| (In Thousands)
Midland manufacturing facility and related assets | $ | 19,646 |  |  | $ | — |  |  | $ | — |  |  | $ | 19,646 |
Warrants liability | (112 | ) |  | — |  |  | — |  |  | (112 | )
Asset for foreign currency derivative contracts | 1,160 |  |  | — |  |  | 1,160 |  |  | — |
Liability for foreign currency derivative contracts | (614 | ) |  | — |  |  | (614 | ) |  | — |
Net asset | $ | 20,080 |  |  |  |  |  |  |

|  |  | Fair Value Measurements Using
| Total as of |  | Quoted Prices in Active Markets for Identical Assets or Liabilities |  | Significant Other Observable Inputs |  | Significant Unobservable Inputs
Description | December 31, 2019 |  | (Level 1) |  | (Level 2) |  | (Level 3)
| (In Thousands)
Warrants liability | $ | (449 | ) |  | $ | — |  |  | $ | — |  |  | $ | (449 | )
Asset for foreign currency derivative contracts | 86 |  |  | — |  |  | 86 |  |  | — |
Liability for foreign currency derivative contracts | (56 | ) |  | — |  |  | (56 | ) |  | — |
Net liability | $ | (419 | ) |  |  |  |  |  |

The fair values of cash, restricted cash, accounts receivable, accounts payable, accrued liabilities, short-term borrowings and long-term debt pursuant to TETRA's ABL Credit Agreement and Term Credit Agreement, and the CCLP Credit Agreement approximate their carrying amounts. The fair values of the publicly traded CCLP 7.25% Senior Notes at March 31, 2020 and December 31, 2019, were approximately $148.0 million and $266.0 million, respectively. Those fair values compare to the face amount of $295.9 million both at March 31, 2020 and December 31, 2019. The fair values of the CCLP 7.50% Senior Secured Notes at March 31, 2020 and December 31, 2019 were approximately $239.8 million and $344.8 million, respectively. These fair values compare
19

Table of Contents
to aggregate principal amount of such notes at both March 31, 2020 and December 31, 2019, of $350.0 million. We based the fair values of the CCLP 7.25% Senior Notes and the CCLP 7.50% Senior Secured Notes as of March 31, 2020 on recent trades for these notes.
NOTE 10 – NET INCOME (LOSS) PER SHARE
The following is a reconciliation of the weighted average number of common shares outstanding with the number of shares used in the computations of net income (loss) per common and common equivalent share:

|  | Three Months Ended March 31,
|  | 2020 |  | 2019
| (In Thousands)
Number of weighted average common shares outstanding |  | 125,587 |  |  | 125,681 |
Assumed exercise of equity awards and warrants |  | — |  |  | — |
Average diluted shares outstanding |  | 125,587 |  |  | 125,681 |

For the three month periods ended March 31, 2020 and March 31, 2019, the average diluted shares outstanding excludes the impact of all outstanding equity awards and warrants, as the inclusion of these shares would have been anti-dilutive due to the net losses recorded during the periods. In addition, for the three month period ended March 31, 2019, the calculation of diluted earnings per common share excludes the impact of the CSI Compressco LP Series A Convertible Preferred Units (the "CCLP Preferred Units"), as the inclusion of the impact from conversion of the CCLP Preferred Units into CCLP common units would have been anti-dilutive.
20

Table of Contents
NOTE 11 – INDUSTRY SEGMENTS
We manage our operations through three Divisions: Completion Fluids & Products, Water & Flowback Services, and Compression.
Summarized financial information concerning the business segments is as follows:

| Three Months Ended March 31,
| 2020 |  | 2019
| (In Thousands)
Revenues from external customers |  |  |  |  |
Product sales |  |  |
Completion Fluids & Products Division | $ | 70,190 |  |  | $ | 57,328 |
Water & Flowback Services Division | 25 |  |  | 364 |
Compression Division | 14,818 |  |  | 34,089 |
Consolidated | $ | 85,033 |  |  | $ | 91,781 |
Services |  |  |
Completion Fluids & Products Division | $ | 5,047 |  |  | $ | 4,253 |
Water & Flowback Services Division | 57,442 |  |  | 78,314 |
Compression Division | 75,420 |  |  | 69,380 |
Consolidated | $ | 137,909 |  |  | $ | 151,947 |
Total revenues |  |  |
Completion Fluids & Products Division | $ | 75,237 |  |  | $ | 61,581 |
Water & Flowback Services Division | 57,467 |  |  | 78,678 |
Compression Division | 90,238 |  |  | 103,469 |
Interdivision eliminations | — |  |  | — |
Consolidated | $ | 222,942 |  |  | $ | 243,728 |
Income (loss) before taxes |  |  |
Completion Fluids & Products Division | $ | 19,396 |  |  | $ | 6,186 |
Water & Flowback Services Division | (2,244 | ) |  | 2,231 |
Compression Division | (12,790 | ) |  | (7,801 | )
Interdivision eliminations | 5 |  |  | 6 |
Corporate Overhead(1) | (13,444 | ) |  | (17,687 | )
Consolidated | $ | (9,077 | ) |  | $ | (17,065 | )

(1) | Amounts reflected include the following general corporate expenses:

| Three Months Ended March 31,
| 2020 |  | 2019
| (In Thousands)
General and administrative expense | $ | 8,081 |  |  | $ | 12,089 |
Depreciation and amortization | 197 |  |  | 168 |
Interest expense | 5,455 |  |  | 5,342 |
Warrants fair value adjustment (income) expense | (338 | ) |  | 407 |
Other general corporate (income) expense, net | 49 |  |  | (319 | )
Total | $ | 13,444 |  |  | $ | 17,687 |

NOTE 12 – SUBSEQUENT EVENTS
In April 2020, we announced our plan to shutdown our Midland manufacturing facility as a result of a decline in orders for new equipment from third parties and the expectation that no incremental equipment will be fabricated for our fleet in the second half of 2020. As a result of the decision to close this facility and solely utilize third party fabricators in the future for our own service fleet, we are pursuing the sale of the Midland facility in an effort to further improve our balance sheet, and have entered into an agreement with a third party purchaser, which
21

Table of Contents
is subject to numerous conditions. While we will continue to operate the facility until the completion and sale of our remaining backlog, we no longer intend to fabricate new compressor packages for sales to third parties. We have and will continue to evaluate the sale of other non-core assets, including our low-horsepower compression fleet. We can provide no assurance that we will consummate a sale of the Midland manufacturing facility, our low-horsepower compression fleet, or any other non-core asset.
In April 2020, we began the process of discontinuing chemical production operations at our El Dorado, Arkansas production facility, which primarily produced calcium chloride from underground brine reserves. The current COVID-19 pandemic and oil oversupply events have led to unprecedented market conditions and this facility’s relatively high fixed costs have led us to rationalize our manufacturing base. We will continue to manufacture and deliver all products through early June 2020, at which time we will begin a sequenced shutdown of the manufacturing facility. We will continue to ship product until the inventory is gone, at which time production operations at the plant will be shutdown. Going forward, we will continue to meet our customer demand for liquid calcium chloride products through our network of other manufacturing plants and terminals.
On April 17, 2020, CCLP announced the commencement of an offer (the "Exchange Offer") to certain eligible noteholders ("Eligible Holders") to exchange any and all of their outstanding 7.25% Senior Notes due 2022 (the “Unsecured Notes”) for newly issued 7.50% Senior Secured First Lien Notes due 2025 and 7.25% Senior Secured Second Lien Notes due 2027. In conjunction with the offer, consents are being solicited from Eligible Holders to eliminate substantially all restrictive covenants and certain of the default provisions in the indenture governing the Unsecured Notes.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of financial condition and results of operations should be read in conjunction with our unaudited consolidated financial statements and accompanying notes included in this Quarterly Report. In addition, the following discussion and analysis also should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on March 16, 2020 ("2019 Annual Report"). This discussion includes forward-looking statements that involve certain risks and uncertainties.
Business Overview
We are a geographically diversified oil and gas services company, focused on completion fluids and associated products and services, comprehensive water management, frac flowback, production well testing and offshore rig cooling services, and compression services and equipment. We operate through three reporting segments organized into three Divisions - Completion Fluids & Products, Water & Flowback Services, and Compression.
Demand for products and services of our Completion Fluids & Products Division has remained strong despite the continued volatility in pricing for oil and uncertainty in many of the markets where we operate, which affects the plans of many of our oil and gas operations customers. During the first quarter of 2020, we experienced increased CBF product sales revenues in the U.S. Gulf of Mexico, including product sales associated with a TETRA CS Neptune completion fluid sale and increased international CBF product sales and domestic manufactured products sales. However, the significant decline in oil prices may adversely affect the demand for our products and services in the near future.
Recent macroeconomic uncertainty resulting from declining oil prices and the COVID-19 pandemic has particularly affected domestic onshore demand for our Water & Flowback Services Division services. We experienced decreased water management services activity during the first quarter of 2020 and without a meaningful recovery, we expect our water management services operations to continue to be negatively impacted in the near future.
Our Compression Division is significantly dependent upon the demand for, and production of, oil and the associated natural gas from unconventional oil and natural gas production in the domestic and international markets in which we operate. During the first part of our quarter, we continued to see increased demand in our products and services, with the exception of a declining backlog for new unit sales. However, during the latter part of the quarter, as the macroeconomic uncertainty resulting from declining oil prices and the COVID-19 pandemic continued, we started to see our customers revise their capital budgets downwards and adjust their operations accordingly. In response to both market uncertainty and the lower levels of spending by our customers, we lowered our projected growth capital expenditures originally intended to increase the horsepower of our fleet. In addition, given the decline
22

Table of Contents
in orders for new equipment to be fabricated and sold to third parties and the expectation that no incremental equipment will be fabricated for our fleet in the second half of 2020, we announced our intentions to close our Midland manufacturing facility, retain equipment design and engineering personnel, and outsource the fabrication of new equipment for our fleet. We no longer intend to design or fabricate new compressor packages for sales to third parties. Due to excess compression equipment in the industry, we have started to and expect to continue to see lower utilization of our compression fleet, client requests to put units on stand-by, and pricing pressures as customers try to reduce their costs.
The COVID-19 pandemic and decline in oil prices had a significant impact on our customers and industry. We concluded these events were indicators of impairment for all asset groups within our Compression Division and certain asset groups in our Completion Fluids & Products Division. As a result, we performed recoverability analyses on the relevant asset groups within these divisions. Based upon these recoverability analyses, we determined that the carrying values of our Midland manufacturing facility and related new unit sales inventory in our Compression Division exceeded their respective fair values. Therefore, we recorded impairments of approximately $5.4 million during the first quarter of 2020 related to these assets. Given the dynamic nature of the events beginning in the first quarter of 2020, we are not able to reasonably estimate how long our operations will be adversely impacted and the full extent these events will have on our operations. As a result, we could have indicators of impairment again in future periods resulting in additional asset impairments.
We are continuing to monitor the 2020 spending plans of our customers and are aggressively managing our working capital and capital expenditure needs in order to maximize our liquidity in the current oil and gas industry environment. Capital expenditure levels continue to be monitored carefully for each of our businesses to ensure that capital investments are only made for the most attractive return on investment. As obtaining additional financing is challenging in the current debt and equity markets, growth capital expenditures are expected to be primarily funded by available cash and cash expected to be provided by operating activities. We intend to manage our flexible cost structure to proactively respond to changing market conditions and execute on actions necessary to manage through these conditions, some of which could result in impairments or restructuring charges in future periods.
Cost reductions we have recently implemented or are in the process of implementing include reductions in 2020 capital expenditures, workforce reductions, salary reductions, the suspension of 401(k) matching contributions for our employees, targeted reduction in SG&A expenses, and negotiated reductions in expenditures with many of our suppliers. Absent a meaningful recovery in natural gas and oil prices and a material improvement in the status of the COVID-19 pandemic, we expect our operations to continue to be negatively impacted, particularly in our onshore producing regions of the United States. We are not able to predict how long market disruptions resulting from the COVID-19 pandemic will continue, or what impact it will ultimately have on our business. Despite that, we will continue to maintain our commitment to safety and service quality for our customers.
How we Evaluate Operations
We use U.S. GAAP financial measures such as revenues, gross profit, income (loss) before taxes, and net cash provided by operating activities, as well as certain non-GAAP financial measures, including Adjusted EBITDA, as performance measures for our business.
Adjusted EBITDA. We view Adjusted EBITDA as one of our primary management tools, and we track it on a monthly basis, both in dollars and as a percentage of revenues (typically compared to the prior month, prior year period, and to budget). We define Adjusted EBITDA as earnings before interest, taxes, depreciation, amortization, impairments and certain other non-cash charges and non-recurring adjustments.
Adjusted EBITDA is used as a supplemental financial measure by our management to:

• | evaluate the financial performance of our assets without regard to financing methods, capital structure, or historical cost basis; and

• | determine our ability to incur and service debt and fund capital expenditures.

23

Table of Contents
The following table reconciles net income (loss) to Adjusted EBITDA for the periods indicated:

| Three Months Ended
| March 31, 2020
| Net Income (Loss), as reported | Tax Provision | Income (Loss) Before Tax, as Reported | Impairments & Special Charges | Adjusted Income (Loss) Before Tax | Interest Expense, Net | Depreciation & Amortization | Equity Comp. Expense | Adjusted EBITDA
| (In Thousands)
Completion Fluids & Products Division |  |  | $ | 19,396 |  | $ | 450 |  | $ | 19,846 |  | $ | (154 | ) | $ | 1,934 |  | $ | — |  | $ | 21,626 |
Water & Flowback Services Division |  |  | (2,244 | ) | 1,607 |  | (637 | ) | (9 | ) | 7,425 |  | — |  | 6,779 |
Compression Division |  |  | (12,790 | ) | 5,971 |  | (6,819 | ) | 12,564 |  | 19,908 |  | 324 |  | 25,977 |
Eliminations and other |  |  | 5 |  | — |  | 5 |  | — |  | (4 | ) | — |  | 1 |
Subtotal |  |  | 4,367 |  | 8,028 |  | 12,395 |  | 12,401 |  | 29,263 |  | 324 |  | 54,383 |
Corporate and other |  |  | (13,444 | ) | 73 |  | (13,371 | ) | 5,455 |  | 197 |  | 1,145 |  | (6,574 | )
TETRA excluding Discontinued Operations | $ | (10,231 | ) | $ | 1,154 |  | $ | (9,077 | ) | $ | 8,101 |  | $ | (976 | ) | $ | 17,856 |  | $ | 29,460 |  | $ | 1,469 |  | $ | 47,809 |
| Three Months Ended
| March 31, 2019
| Net Income (Loss), as reported | Tax Provision | Income (Loss) Before Tax, as Reported | Impairments & Special Charges | Adjusted Income (Loss) Before Tax | Interest Expense, Net | Depreciation & Amortization | Equity Comp. Expense | Adjusted EBITDA
| (In Thousands)
Completion Fluids & Products Division |  |  | $ | 6,186 |  | $ | 683 |  | $ | 6,869 |  | $ | (179 | ) | $ | 3,665 |  | $ | — |  | $ | 10,355 |
Water & Flowback Services Division |  |  | 2,231 |  | (400 | ) | 1,831 |  | 4 |  | 8,267 |  | — |  | 10,102 |
Compression Division |  |  | (7,801 | ) | 1,610 |  | (6,191 | ) | 13,213 |  | 18,532 |  | 365 |  | 25,919 |
Eliminations and other |  |  | 6 |  | — |  | 6 |  | (1 | ) | (4 | ) | — |  | 1 |
Subtotal |  |  | 622 |  | 1,893 |  | 2,515 |  | 13,037 |  | 30,460 |  | 365 |  | 46,377 |
Corporate and other |  |  | (17,687 | ) | 331 |  | (17,356 | ) | 5,342 |  | 168 |  | 1,800 |  | (10,046 | )
TETRA excluding Discontinued Operations | $ | (18,674 | ) | $ | 1,609 |  | $ | (17,065 | ) | $ | 2,224 |  | $ | (14,841 | ) | $ | 18,379 |  | $ | 30,628 |  | $ | 2,165 |  | $ | 36,331 |

Adjusted EBITDA is a financial measure that is not in accordance with U.S. GAAP and should not be considered an alternative to net income, operating income, cash flows from operating activities, or any other measure of financial performance presented in accordance with U.S. GAAP. This measure may not be comparable to similarly titled financial metrics of other entities, as other entities may not calculate Adjusted EBITDA in the same manner as we do. Management compensates for the limitations of Adjusted EBITDA as analytical tools by reviewing the comparable U.S. GAAP measures, understanding the differences between the measures, and incorporating this knowledge into management’s decision-making processes.
Critical Accounting Policies and Estimates
There have been no material changes or developments in the evaluation of the accounting estimates and
the underlying assumptions or methodologies pertaining to our Critical Accounting Policies and Estimates disclosed
in our 2019 Annual Report. In preparing our consolidated financial statements, we make assumptions, estimates, and judgments that affect the amounts reported. These judgments and estimates may change as new events occur, as new information is acquired, and as changes in our operating environments are encountered. Actual results are likely to differ from our current estimates, and those differences may be material.
24

Table of Contents
Results of Operations
Three Months Ended March 31, 2020 compared with three months ended March 31, 2019.
Consolidated Comparisons

| Three Months Ended March 31, |  | Period to Period Change
| 2020 |  | 2019 |  | 2020 vs 2019 |  | % Change
| (In Thousands, Except Percentages)
Revenues | $ | 222,942 |  |  | $ | 243,728 |  |  | $ | (20,786 | ) |  | (8.5 | )%
Gross profit | 39,417 |  |  | 36,210 |  |  | 3,207 |  |  | 8.9 | %
Gross profit as a percentage of revenue | 17.7 | % |  | 14.9 | % |  |  |  |  |  |
General and administrative expense | 30,537 |  |  | 34,277 |  |  | (3,740 | ) |  | (10.9 | )%
General and administrative expense as a percentage of revenue | 13.7 | % |  | 14.1 | % |  |  |  |  |  |
Interest expense, net | 17,856 |  |  | 18,379 |  |  | (523 | ) |  | (2.8 | )%
Warrants fair value adjustment (income) expense | (338 | ) |  | 407 |  |  | (745 | ) |  | (183.0 | )%
CCLP Series A Preferred Units fair value adjustment (income) expense | — |  |  | 1,163 |  |  | (1,163 | ) |  | (100.0 | )%
Other (income) expense, net | 439 |  |  | (951 | ) |  | 1,390 |  |  | (146.2 | )%
Loss before taxes and discontinued operations | (9,077 | ) |  | (17,065 | ) |  | 7,988 |  |  | 46.8 | %
Loss before taxes and discontinued operations as a percentage of revenue | (4.1 | )% |  | (7.0 | )% |  |  |  |  |  |
Provision for income taxes | 1,154 |  |  | 1,609 |  |  | (455 | ) |  | (28.3 | )%
Loss before discontinued operations | (10,231 | ) |  | (18,674 | ) |  | 8,443 |  |  | (45.2 | )%
Discontinued operations: |  |  |  |  |  |  |
Loss from discontinued operations, net of taxes | (145 | ) |  | (426 | ) |  | 281 |  |  | (66.0 | )%
Net loss | (10,376 | ) |  | (19,100 | ) |  | 8,724 |  |  | (45.7 | )%
Loss attributable to noncontrolling interest | 8,825 |  |  | 8,262 |  |  | 563 |  |  | 6.8 | %
Net loss attributable to TETRA stockholders | $ | (1,551 | ) |  | $ | (10,838 | ) |  | $ | 9,287 |  |  | (85.7 | )%

Consolidated revenues for the current year period decreased compared to the prior year period primarily due to decreased revenues in our Water & Flowback Services and Compression Divisions, which decreased by $21.2 million and $13.2 million, respectively. The decrease in revenues for the Water & Flowback Services Division was primarily due to decreased water management services activity. The decreased revenues of the Compression Division were primarily due to decreased deliveries of new compressor packages. These decreases were partially offset by an increase in revenues in our Completion Fluids & Products Division of $13.7 million primarily due to increased CBF product sales revenues in the U.S. Gulf of Mexico, including product sales associated with a TETRA CS Neptune completion fluid sale, and increased international CBF product sales and domestic manufactured products sales. See Divisional Comparisons section below for additional discussion.
Consolidated gross profit increased during the current year period compared to the prior year period primarily due to the increased profitability of our Completion Fluids & Products Division. The increased gross profit from the Completion Fluids & Products Division was offset by the decreased gross profit of our Water & Flowback Services Division. Despite the improvement in activity levels of our Completion Fluids & Products Division, onshore activity levels remained flat and the impact of pricing pressures continues to challenge profitability in certain markets. Operating expenses reflect the decrease in consolidated revenues, as well as aggressive management of operating costs and headcount.
Consolidated general and administrative expenses decreased during the current year period compared to the prior year period primarily due to decreased salary related expenses of $4.8 million and decreased general expenses of $0.2 million. These decreases were offset by increased bad debt expense of $1.0 million and increased professional services fees of $0.4 million. Decreased general and administrative expenses were driven primarily by our Water & Flowback Services Division and Corporate Divisions. General and administrative expense as a percentage of revenues decreased compared to the prior year period.
25

Table of Contents
Consolidated interest expense, net, decreased in the current year period primarily due to a decrease in Compression Division interest expense associated with the expense of CCLP Series A Preferred units that was incurred in the prior year period. Interest expense during the current year period and the prior year period includes $1.1 million and $1.0 million, respectively, of finance cost amortization.
The Warrants are accounted for as a derivative liability in accordance with ASC 815 and therefore they are classified as a long-term liability on our consolidated balance sheet at their fair value. Increases (or decreases) in the fair value of the Warrants are generally associated with increases (or decreases) in the trading price of our common stock, resulting in adjustments to earnings for the associated valuation losses (gains), and resulting in future volatility of our earnings during the period the Warrants are outstanding.
The CCLP Preferred Units were eligible to be settled using a variable number of CCLP common units, and therefore the fair value of the CCLP Preferred Units was classified as a long-term liability on our consolidated balance sheets in accordance with ASC 480. Because the CCLP Preferred Units were convertible into CCLP common units at the option of the holder, the fair value of the CCLP Preferred Units generally increased or decreased with the trading price of the CCLP common units, and this increase (decrease) in CCLP Preferred Unit fair value was charged (credited) to earnings, as appropriate. The last remaining outstanding CCLP Preferred Units were redeemed for cash on August 8, 2019.
Consolidated other (income) expense, net, was $0.4 million of expense during the current year period compared to $1.0 million of income during the prior year period. The increase in expense is primarily due to $1.5 million of increased foreign currency losses due to the devaluation of the Mexican peso and increased deferred compensation expense of $0.4 million. The increases in expense were offset by $0.6 million of gains associated with the sale of assets.
Our consolidated provision for income taxes for the current year period is primarily attributable to taxes in certain foreign jurisdictions and Texas gross margin taxes. Our consolidated effective tax rate for the three month period ended March 31, 2020 of negative 12.7% was primarily the result of losses generated in entities for which no related tax benefit has been recorded. The losses generated by these entities do not result in tax benefits due to offsetting valuation allowances being recorded against the related net deferred tax assets. We establish a valuation allowance to reduce the deferred tax assets when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Included in our deferred tax assets are net operating loss carryforwards and tax credits that are available to offset future income tax liabilities in the U.S. as well as in certain foreign jurisdictions.
Divisional Comparisons
Completion Fluids & Products Division

| Three Months Ended March 31, |  | Period to Period Change
| 2020 |  | 2019 |  | 2020 vs 2019 |  | % Change
| (In Thousands, Except Percentages)
Revenues | $ | 75,237 |  |  | $ | 61,581 |  |  | $ | 13,656 |  |  | 22.2 | %
Gross profit | 25,964 |  |  | 10,664 |  |  | 15,300 |  |  | 143.5 | %
Gross profit as a percentage of revenue | 34.5 | % |  | 17.3 | % |  |  |  |  |  |
General and administrative expense | 5,934 |  |  | 4,728 |  |  | 1,206 |  |  | 25.5 | %
General and administrative expense as a percentage of revenue | 7.9 | % |  | 7.7 | % |  |  |  |  |  |
Interest (income) expense, net | (154 | ) |  | (179 | ) |  | 25 |  |  | (14.0 | )%
Other (income) expense, net | 788 |  |  | (71 | ) |  | 859 |  |  |  |
Income before taxes | $ | 19,396 |  |  | $ | 6,186 |  |  | $ | 13,210 |  |  | 213.5 | %
Income before taxes as a percentage of revenue | 25.8 | % |  | 10.0 | % |  |  |  |  |  |

The increase in Completion Fluids & Products Division revenues during the current year period compared to the prior year period was primarily due to $12.9 million of increased product sales revenue which was partly due to increased CBF product sales revenues in the U.S. Gulf of Mexico, including product sales associated with a TETRA CS Neptune completion fluid sale. Increased revenues were also the result of improved markets for CBF product sales in international locations, including South America and domestic manufactured products sales. Additionally,
26

Table of Contents
service revenues increased $0.8 million, primarily due to increased filtration and engineering work in the U.S. Gulf of Mexico associated with fluid sales.
Completion Fluids & Products Division gross profit during the current year period increased compared to the prior year period primarily due to the profitability associated with the increased manufactured products and international CBF sales revenues. Completion Fluids & Products Division profitability in future periods will be affected by the mix of its products and services, including the timing of TETRA CS Neptune completion fluid projects.
The Completion Fluids & Products Division reported an increase in pretax earnings during the current year period compared to the prior year period due to the increase in gross profit discussed above. Completion Fluids & Products Division administrative cost levels increased compared to the prior year period primarily due to increased salary and employee-related expenses of $1.2 million. Other expense, net increased as compared to prior year period primarily due to $0.8 million of foreign currency losses.
Water & Flowback Services Division

| Three Months Ended March 31, |  | Period to Period Change
| 2020 |  | 2019 |  | 2020 vs 2019 |  | % Change
| (In Thousands, Except Percentages)
Revenues | $ | 57,467 |  |  | $ | 78,678 |  |  | $ | (21,211 | ) |  | (27.0 | )%
Gross profit | 3,267 |  |  | 8,851 |  |  | (5,584 | ) |  | (63.1 | )%
Gross profit as a percentage of revenue | 5.7 | % |  | 11.2 | % |  |  |  |  |  |
General and administrative expense | 6,334 |  |  | 6,796 |  |  | (462 | ) |  | (6.8 | )%
General and administrative expense as a percentage of revenue | 11.0 | % |  | 8.6 | % |  |  |  |  |  |
Interest (income) expense, net | (9 | ) |  | 4 |  |  | (13 | ) |  | (40.0 | )%
Other (income) expense, net | (814 | ) |  | (180 | ) |  | (634 | ) |  | (137.3 | )%
Income (loss) before taxes | $ | (2,244 | ) |  | $ | 2,231 |  |  | $ | (4,475 | ) |  | 200.6 | %
Income (loss) before taxes as a percentage of revenue | (3.9 | )% |  | 2.8 | % |  |  |  |  |  |

Water & Flowback Services Division service and product revenues decreased $21.2 million during the current year period compared to the prior year period due to decreased water management services activity associated with economic uncertainty and decreased international equipment sales activity.
The Water & Flowback Services Division reflected decreased gross profit during the current year period compared to the prior year period partly due to decreased gross profit consistent with decreased revenues and partly due to decreased gross profit as a result of certain high-margin projects performed during the prior year.
The Water & Flowback Services Division reported a pretax loss compared to a pretax income in the prior year period, primarily due to the decrease in gross profit described above. General and administrative expenses decreased primarily due decreased wage and benefit related expenses of $1.0 million and decreased general expenses of $0.4 million offset by increased bad debt expense of $0.7 million and increased professional fees of $0.2 million. The Water & Flowback Services Division reported increased other income, net, primarily due to increased gains associated with the disposal of assets of $0.7 million and foreign currency gains of $0.3 million, offset by decreased income of $0.4 million associated with the remeasurement of contingent purchase price consideration in the prior year.
27

Table of Contents
Compression Division

| Three Months Ended March 31, |  | Period to Period Change
| 2020 |  | 2019 |  | 2020 vs 2019 |  | % Change
| (In Thousands, Except Percentages)
Revenues | $ | 90,238 |  |  | $ | 103,469 |  |  | $ | (13,231 | ) |  | (12.8 | )%
Gross profit | 10,380 |  |  | 16,859 |  |  | (6,479 | ) |  | (38.4 | )%
Gross profit as a percentage of revenue | 11.5 | % |  | 16.3 | % |  |  |  |  |  |
General and administrative expense | 10,189 |  |  | 10,664 |  |  | (475 | ) |  | (4.5 | )%
General and administrative expense as a percentage of revenue | 11.3 | % |  | 10.3 | % |  |  |  |  |  |
Interest expense, net | 12,564 |  |  | 13,213 |  |  | (649 | ) |  | (4.9 | )%
CCLP Series A Preferred fair value adjustment (income) expense | — |  |  | 1,163 |  |  | (1,163 | ) |  | 100.0 | %
Other (income) expense, net | 417 |  |  | (380 | ) |  | 797 |  |  | (209.7 | )%
Loss before taxes | $ | (12,790 | ) |  | $ | (7,801 | ) |  | $ | (4,989 | ) |  | (64.0 | )%
Loss before taxes as a percentage of revenue | (14.2 | )% |  | (7.5 | )% |  |  |  |  |  |

Compression Division revenues decreased during the current year period compared to the prior year period primarily due to a $19.3 million decrease in product sales revenues due to a decrease in deliveries of new compressors compared to the prior year. Overall, new unit sale booking levels declined in the first quarter of 2020 as customers substantially cut spending on infrastructure projects. The decrease in product sales was offset by a $6.0 million increase in service revenues from compression and aftermarket services operations. The increase in service revenues was primarily due to increases in our high-horsepower fleet during 2019 and resulting increased horsepower in service during the current year period compared to the prior year period and pricing secured in 2019 that was realized during the first quarter of 2020.
Compression Division gross profit decreased during the current year period compared to the prior year due to decreased revenues discussed above and the impairment of $5.4 million associated with our Midland manufacturing facility and related assets.
The Compression Division recorded increased pretax loss in the current year period compared to the prior year period due to the decreased gross profit discussed above. Interest expense decreased compared to the prior year period due to decreased interest associated with the CCLP Series A Preferred units that was incurred in the prior year period. General and administrative expense levels decreased compared to the prior year period, due to decreased salary and employee-related expenses, including the impact of decreased headcount, incentives and equity compensation of $0.7 million and decreased general expenses of $0.3 million. These decreases were offset by increased professional services of $0.3 million and increased bad debt expense of $0.2 million. Other (income) expense, net changed from income of $0.4 million income in the prior year period to $0.4 million expense in the current year period. The change from income to expense is primarily due to $1.2 million on increased foreign currency losses due to the devaluation of the peso offset by decreased expense of $0.5 million associated with the redemption premium incurred during the prior year period in connection with the redemption of Preferred Units for cash. The last remaining outstanding CCLP Preferred Units were redeemed for cash on August 8, 2019.
Corporate Overhead

| Three Months Ended March 31, |  | Period to Period Change
| 2020 |  | 2019 |  | 2020 vs 2019 |  | % Change
| (In Thousands, Except Percentages)
Depreciation and amortization | $ | 197 |  |  | $ | (168 | ) |  | $ | 365 |  |  | 217.3 | %
General and administrative expense | 8,081 |  |  | 12,089 |  |  | (4,008 | ) |  | (33.2 | )%
Interest expense, net | 5,455 |  |  | 5,342 |  |  | 113 |  |  | 2.1 | %
Warrants fair value adjustment (income) expense | (338 | ) |  | 407 |  |  | (745 | ) |  | (183.0 | )%
Other (income) expense, net | 49 |  |  | (319 | ) |  | 368 |  |  | (115.4 | )%
Loss before taxes | $ | (13,444 | ) |  | $ | (17,687 | ) |  | $ | 4,243 |  |  | 24.0 | %

Corporate Overhead pretax loss decreased during the current year period compared to the prior year period primarily due to decreased general and administrative expenses. Corporate general and administrative expense
28

Table of Contents
decreased primarily due to decreased salary related expense of $4.4 million. This decrease was offset by $0.3 million of decreased general expenses and $0.1 million of decreased professional fees. The fair value of the outstanding Warrants liability resulted in a $0.3 million credit to earnings in the current year period compared to an $0.4 million charge to earnings during the prior year period. In addition, the other (income) expense, net change was primarily associated with adjustments to deferred compensation plans.
Liquidity and Capital Resources
We believe that our and CCLP's separate capital structures allow us to meet our respective financial obligations, despite current uncertain operating conditions and financial markets. As of March 31, 2020, we and CCLP are in compliance with all covenants of our respective debt agreements. Information about the terms and covenants of our debt agreements can be found in our 2019 Annual Report.
Because of the level of consolidated debt, we believe it is important to consider our capital structure and that of CCLP separately, as there are no cross default provisions, cross collateralization provisions, or cross guarantees between CCLP's debt and TETRA's debt. Our consolidated debt outstanding has a carrying value of approximately $845.8 million as of March 31, 2020. However, approximately $638.4 million of this consolidated debt balance is owed by CCLP and is serviced from the cash balances and cash flows of CCLP, and $346.6 million of which is secured by certain of CCLP's assets. Through our common unit ownership interest in CCLP, which was approximately 34% as of March 31, 2020, and ownership of an approximate 1.4% general partner interest, we receive our share of the distributable cash flows of CCLP through its quarterly cash distributions. Approximately $7.4 million of the $29.5 million of the cash balance reflected on our consolidated balance sheet is owned by CCLP and is not accessible by us. The following table provides condensed consolidating balance sheet information reflecting TETRA's net assets and CCLP's net assets that service and secure TETRA's and CCLP's respective capital structures.

| March 31, 2020
Condensed Consolidating Balance Sheet | TETRA |  | CCLP |  | Eliminations |  | Consolidated
| (In Thousands)
Cash, excluding restricted cash | $ | 22,057 |  |  | $ | 7,416 |  |  | $ | — |  |  | $ | 29,473 |
Affiliate receivables | 14,964 |  |  | — |  |  | (14,964 | ) |  | — |
Other current assets | 194,292 |  |  | 140,215 |  |  | — |  |  | 334,507 |
Property, plant and equipment, net | 112,095 |  |  | 628,152 |  |  | — |  |  | 740,247 |
Long-term affiliate receivables | 11,618 |  |  | — |  |  | (11,618 | ) |  | — |
Other assets, including investment in CCLP | 22,474 |  |  | 58,519 |  |  | 84,544 |  |  | 165,537 |
Total assets | $ | 377,500 |  |  | $ | 834,302 |  |  | $ | 57,962 |  |  | $ | 1,269,764 |
Affiliate payables | $ | — |  |  | $ | 14,964 |  |  | $ | (14,964 | ) |  | $ | — |
Other current liabilities | 80,576 |  |  | 114,620 |  |  | — |  |  | 195,196 |
Long-term debt, net | 207,413 |  |  | 638,429 |  |  | — |  |  | 845,842 |
Warrants liability | 112 |  |  | — |  |  | — |  |  | 112 |
Long-term affiliate payable | — |  |  | 11,618 |  |  | (11,618 | ) |  | — |
Other non-current liabilities | 61,771 |  |  | 19,912 |  |  | — |  |  | 81,683 |
Total equity | 27,628 |  |  | 34,759 |  |  | 84,544 |  |  | 146,931 |
Total liabilities and equity | $ | 377,500 |  |  | $ | 834,302 |  |  | $ | 57,962 |  |  | $ | 1,269,764 |

As of March 31, 2020, subject to compliance with the covenants, borrowing base requirements, and other provisions of the agreement that may limit borrowings, we had $40.8 million of availability under the ABL Credit Agreement. The amounts we may borrow under the ABL Credit Agreement are derived from our accounts receivable and certain inventory. Decreases in the amount of our accounts receivable and the value of our inventory would result in reduced borrowing availability under the Credit Agreement. As of March 31, 2020, and subject to compliance with the covenants, borrowing base requirements, and other provisions of the agreement that may limit borrowings under the CCLP Credit Agreement, CCLP had availability of $20.4 million. See CCLP Financing Activities below for further discussion.
29

Table of Contents
Our consolidated sources (uses) of cash during the three months ended March 31, 2020 and 2019 are as follows:

| Three Months Ended March 31,
| 2020 |  | 2019
| (In Thousands)
Operating activities | $ | 22,176 |  |  | $ | 7,412 |
Investing activities | (10,615 | ) |  | (31,726 | )
Financing activities | 1,138 |  |  | 21,312 |

Operating Activities
Consolidated cash flows provided by operating activities increased by $14.8 million. CCLP generated $13.4 million of our consolidated cash flows provided by operating activities during the three months ended March 31, 2020 compared to $31.6 million during the corresponding prior year period. Operating cash flows increased primarily due to improved operating profitability of the Completion Fluids and Products Division. We continue to monitor customer credit risk in the current environment and focus on serving larger capitalized oil and gas operators and national oil companies.
Investing Activities
Total cash capital expenditures during the first three months of 2020 were $12.4 million, which is net of $1.9 million cost of compressors sold. Our Completion Fluids & Products Division spent $0.9 million on capital expenditures, the majority of which related to plant and facility additions. Our Water & Flowback Services Division spent $4.7 million on capital expenditures, primarily to add to and maintain its water management equipment fleet. Our Compression Division spent $6.7 million, primarily for growth capital expenditure projects and to maintain its compression fleet.
Historically, a significant majority of our planned capital expenditures has been related to identified opportunities to grow and expand our existing businesses. However, such expenditures have recently been, and may continue to be, postponed or canceled as we are reviewing all capital expenditure plans carefully in an effort to conserve cash. We currently have no long-term capital expenditure commitments. The deferral of capital projects could affect our ability to expand our operations in the future. Excluding our Compression Division, we expect to spend approximately $10.0 million to $15.0 million during 2020 on capital expenditures, primarily to expand and maintain our Water & Flowback Services Division equipment fleet.
Our Compression Division has adjusted its expected capital spend downward to approximately $28.0 million to $35.0 million during 2020 primarily to maintain its compression fleet.
If the forecasted demand for our products and services increases or decreases, the amount of planned expenditures on growth and expansion may be adjusted.
Financing Activities
During the first three months of 2020, the total amount of consolidated cash provided by financing activities was $1.1 million, primarily due to borrowings under our ABL Credit Agreement. We and CCLP may supplement our existing cash balances and cash flow from operating activities with short-term borrowings, long-term borrowings, issuances of equity and debt securities, and other sources of capital. We and CCLP are aggressively managing our working capital and capital expenditure needs in order to maximize our liquidity in the current environment.
TETRA Long-Term Debt
Asset-Based Credit Agreement. The ABL Credit Agreement provides for a senior secured revolving credit facility of up to $100 million, subject to a borrowing base to be determined by reference to the value of inventory and accounts receivable, and includes a sublimit of $20.0 million for letters of credit and a swingline loan sublimit of $10.0 million. The amounts we may borrow under the ABL Credit Agreement are derived from our accounts receivable and certain inventory. Decreases in the amount of our accounts receivable and the value of our inventory would result in reduced borrowing availability under the ABL Credit Agreement. The ABL Credit Agreement is
30

Table of Contents
scheduled to mature on September 10, 2023. As of May 5, 2020, we have $1.0 million outstanding under our ABL Credit Agreement and $6.4 million letters of credit, resulting in $45.9 million of availability.
Term Credit Agreement. The Term Credit Agreement is scheduled to mature on September 10, 2025. As of May 5, 2020, $220.5 million in aggregate principal amount of our Term Credit Agreement is outstanding.
CCLP Financing Activities
CCLP Preferred Units. In January 2019 CCLP began redeeming its Series A Preferred Units for cash, resulting in 783,046 Preferred Units being redeemed during the three months ended March 31, 2019 for an aggregate of $8.3 million, which includes approximately $0.4 million of redemption premiums that were paid. The last redemption of the remaining Preferred Units, along with a final cash payment made in lieu of paid-in-kind units, occurred on August 8, 2019.
CCLP Bank Credit Facility. All the obligations of CCLP and two of its wholly owned subsidiaries (collectively the "CCLP Borrowers") under the CCLP Credit Agreement are guaranteed by certain of their existing and future domestic subsidiaries. The CCLP Credit Agreement, as amended, includes a maximum credit commitment of $50.0 million which is available for loans, letters of credit (with a sublimit of $25.0 million), and swingline loans (with a sublimit of $5.0 million), subject to a borrowing base to be determined by reference to the value of accounts receivable and certain inventory of the CCLP Borrowers. Such maximum credit commitment may be increased by $25.0 million in accordance with the terms and conditions of the CCLP Credit Agreement. As of March 31, 2020, and subject to compliance with the covenants, borrowing base, and other provisions of the agreements that may limit borrowings under the CCLP Credit Agreement, CCLP had availability of $20.4 million.
The CCLP Borrowers may borrow funds under the CCLP Credit Agreement to pay fees and expenses related to the CCLP Credit Agreement and for the CCLP Borrower's ongoing working capital needs and for general partnership purposes. The revolving loans under the CCLP Credit Agreement may be voluntarily prepaid, in whole or in part, without premium or penalty, subject to breakage or similar costs. The maturity date of the CCLP Credit Agreement is June 29, 2023. As of March 31, 2020, CCLP had a $3.0 million outstanding balance and had $3.0 million in letters of credit against the CCLP Credit Agreement. As of May 5, 2020, CCLP has $6.7 million balance outstanding under the CCLP Credit Agreement and $2.7 million in letters of credit, resulting in $16.1 million of availability. The amounts the CCLP Borrowers may borrow under the CCLP Credit Agreement are derived from CCLP’s accounts receivable and certain inventory. Decreases in the amount of CCLP’s accounts receivable and the value of its inventory would result in reduced borrowing availability under the CCLP Credit Agreement. The CCLP Borrowers are in discussions with the lenders under the CCLP Credit Agreement regarding a potential amendment that would permit the CCLP Borrowers to incur second-priority liens on collateral pledged under the CLLP Senior Secured Notes. This amendment will be entered into if the exchange offer discussed below is completed. We anticipate the terms of the amendment to the CCLP Credit Agreement may include, among other items, the inclusion of a $5.0 million reserve which would result in reduced borrowing availability. We can provide no assurance the amendment will be entered into or what its final terms might be.
CCLP Senior Secured Notes. As of May 5, 2020, $350.0 million in aggregate principal amount was outstanding. The CCLP Senior Secured Notes accrue interest at a rate of 7.50% per annum and are scheduled to mature on April 1, 2025.
CCLP Senior Notes. As of May 5, 2020, $295.9 million in aggregate principal amount was outstanding. The CCLP Senior Notes accrue interest at a rate of 7.25% per annum and are scheduled to mature on August 15, 2022.
On April 17, 2020, CCLP announced the commencement of an offer (the "Exchange Offer") to certain eligible noteholders ("Eligible Holders") to exchange any and all of their outstanding CCLP Senior Notes due 2022 (the “Unsecured Notes”) for newly issued CCLP 7.50% Senior Secured First Lien Notes due 2025 and CCLP 7.25% Senior Secured Second Lien Notes due 2027. In conjunction with the offer, consents are being solicited from Eligible Holders to eliminate substantially all restrictive covenants and certain of the default provisions in the indenture governing the Unsecured Notes. On May 1, 2020, CCLP extended the early tender time for the Exchange Offer from 5:00 p.m., New York City time, on April 30, 2020 to 11:59 p.m., New York City time, on May 14, 2020 (which is the expiration time of the Exchange Offer), unless extended or earlier terminated by CCLP. Eligible Holders that validly tender and do not validly withdraw their Unsecured Notes in the exchange offer prior to the Expiration Time will receive $700 in principal amount of new CCLP 7.50% Senior Secured First Lien Notes or, as applicable and subject to proration, $750 principal amount of CCLP 7.25% Senior Secured Second Lien Notes for
31

Table of Contents
each $1,000 principal amount of Unsecured Notes tendered. CCLP can terminate, withdraw, amend or extend the Exchange Offer at any time, subject to applicable law. There can be no assurance that the Exchange Offer will be completed.
Other Sources and Uses
In addition to the aforementioned credit facilities and senior notes, we and CCLP fund our respective short-term liquidity requirements from cash generated by our respective operations and from short-term vendor financing. Should additional capital be required, the ability to raise such capital through the issuance of additional debt or equity securities may currently be limited. Instability or volatility in the capital markets at the times we need to access capital may affect the cost of capital and the ability to raise capital for an indeterminable length of time. If it is necessary to issue additional equity to fund our capital needs, additional dilution of our common stockholders will occur. We periodically evaluate engaging in strategic transactions and may consider divesting non-core assets where our evaluation suggests such transaction is in the best interest of our business.
On April 11, 2019, we filed a universal shelf Registration Statement on Form S-3 with the SEC. On May 1, 2019, the Registration Statement on Form S-3 was declared effective by the SEC. Pursuant to this registration statement, we have the ability to sell debt or equity securities in one or more public offerings up to an aggregate public offering price of $464.1 million, inclusive of $64.1 million of our common stock issuable upon conversion of our currently outstanding warrants. This shelf registration statement currently provides us additional flexibility with regard to potential financings that we may undertake when market conditions permit or our financial condition may require.
The Second Amended and Restated Partnership Agreement of CCLP requires that within 45 days after the end of each quarter, CCLP distribute all of its available cash, as defined in the Second Amended and Restated Partnership Agreement, to its common unitholders of record on the applicable record date. During the three months ended March 31, 2020, CCLP distributed $0.5 million in cash, including $0.3 million to its public unitholders. The amount of quarterly distributions is determined based on a variety of factors, including estimates of CCLP's cash needs to fund its future operating, investing, and debt service requirements. There can be no assurance that quarterly distributions from CCLP will increase from this amount per unit going forward.
Off Balance Sheet Arrangements
As of March 31, 2020, we had no “off balance sheet arrangements” that may have a current or future material effect on our consolidated financial condition or results of operations.
Commitments and Contingencies
Litigation
We are named defendants in several lawsuits and respondents in certain governmental proceedings arising in the ordinary course of business. While the outcome of lawsuits or other proceedings against us cannot be predicted with certainty, management does not consider it reasonably possible that a loss resulting from such lawsuits or other proceedings in excess of any amounts accrued has been incurred that is expected to have a material adverse impact on our financial condition, results of operations, or liquidity.
Contingencies of Discontinued Operations
In early 2018, we closed the Maritech Asset Purchase and Sale Agreement with Orinoco Natural Resources, LLC ("Orinoco") that provided for the purchase by Orinoco of Maritech's remaining oil and gas properties and related assets. Shortly thereafter, we closed the Maritech Membership Interest Purchase and Sale Agreement with Orinoco that provided for the purchase by Orinoco of all of the outstanding membership interests in Maritech. As a result of these transactions, we have effectively exited the business of our former Maritech segment.
32

Table of Contents
Under the Maritech Asset Purchase and Sale Agreement, Orinoco assumed all of Maritech’s decommissioning liabilities related to the leases sold to Orinoco (the “Orinoco Lease Liabilities”) and, under the Maritech Membership Interest Purchase and Sale Agreement, Orinoco assumed all other liabilities of Maritech, including the decommissioning liabilities associated with the oil and gas properties previously sold by Maritech (the “Legacy Liabilities”), subject to certain limited exceptions unrelated to the decommissioning liabilities. To the extent that Maritech or Orinoco fails to satisfy decommissioning liabilities associated with any of the Orinoco Lease Liabilities or the Legacy Liabilities, we may be required to satisfy such liabilities under third party indemnity agreements and corporate guarantees that we previously provided to the US Department of the Interior and other parties, respectively.
Pursuant to a Bonding Agreement entered into as part of these transactions (the "Bonding Agreement"), Orinoco provided non-revocable performance bonds in an aggregate amount of $46.8 million to cover the performance by Orinoco and Maritech of the asset retirement obligations of Maritech (the “Initial Bonds”) and agreed to replace, within 90 days following the closing, the Initial Bonds with other non-revocable performance bonds, meeting certain requirements, in the aggregate sum of $47.0 million (collectively, the “Interim Replacement Bonds”). Orinoco further agreed to replace, within 180 days following the closing, the Interim Replacement Bonds with a maximum of three non-revocable performance bonds in the aggregate sum of $47.0 million, meeting certain requirements (the “Final Bonds”). Among the other requirements of the Final Bonds was that they must provide coverage for all of the asset retirement obligations of Maritech instead of only relating to specific properties. In the event Orinoco did not provide the Interim Replacement Bonds or the Final Bonds, Orinoco was required to make certain cash escrow payments to us.
The payment obligations of Orinoco under the Bonding Agreement were guaranteed by Thomas M. Clarke and Ana M. Clarke pursuant to a separate guaranty agreement (the “Clarke Bonding Guaranty Agreement”). Orinoco has not delivered such replacement bonds and neither it nor the Clarkes has made any of the agreed upon cash escrow payments and we filed a lawsuit against Orinoco and the Clarkes to enforce the terms of the Bonding Agreement and the Clarke Bonding Guaranty Agreement. A summary judgment was initially granted in favor of Orinoco and the Clarkes which dismissed our claims against Orinoco under the Bonding Agreement and against the Clarkes under the Clarke Bonding Guaranty Agreement. We filed an appeal and also asked the trial court to grant a new trial on the summary judgment or to modify the judgment because we believe this judgment should not have been granted. On November 5, 2019, the trial court signed an order granting our motion for new trial and vacating the prior order granting summary judgment for Orinoco and the Clarkes. The parties are awaiting direction from the court on a new scheduling order and/or trial setting. The Initial Bonds, which are non-revocable, remain in effect.
If we become liable in the future for any decommissioning liability associated with any property covered by either an Initial Bond or an Interim Replacement Bond while such bonds are outstanding and the payment made to us under such bond is not sufficient to satisfy such liability, the Bonding Agreement provides that Orinoco will pay us an amount equal to such deficiency and if Orinoco fails to pay any such amount, such amount must be paid by the Clarkes under the Clarke Bonding Guaranty Agreement. However, if the Final Bonds or the full amount of the escrowed cash have been provided, neither Orinoco nor the Clarkes would be liable to pay us for any such deficiency. Our financial condition and results of operations may be negatively affected if Orinoco is unable to cover any such deficiency or if we become liable for a significant portion of the decommissioning liabilities.
In early 2018, we also closed the sale of our Offshore Division to Epic Companies, LLC (“Epic Companies,” formerly known as Epic Offshore Specialty, LLC). Part of the consideration we received was a promissory note of Epic Companies in the original principal amount of $7.5 million (the “Epic Promissory Note”) payable to us in full, together with interest at a rate of 1.52% per annum, on December 31, 2019, along with a personal guaranty agreement from Thomas M. Clarke and Ana M. Clarke guaranteeing the payment obligations of Epic Companies pursuant to the Epic Promissory Note (the “Clarke Promissory Note Guaranty Agreement”). Additionally, pursuant to the Equity Interest Purchase Agreement (the “Offshore Services Purchase Agreement”) and other agreements with Epic Companies, certain other amounts relating to the Offshore Division totaling approximately $1.5 million were payable to us. At the end of August 2019, Epic Companies filed for bankruptcy. We recorded a reserve of $7.5 million for the full amount of the promissory note, including accrued interest, and the certain other receivables in the amount of $1.5 million during the quarter ended September 30, 2019. The Epic Promissory Note became due on December 31, 2019 but neither Epic nor the Clarkes made the required payment. Upon the default by Epic and the Clarkes, we filed a lawsuit against the Clarkes on January 15, 2020 in Montgomery County, Texas for breach of the Clarke Promissory Note Guaranty Agreement, seeking the amounts due under the Epic Promissory Note and related interest, as well as attorneys’ fees and expenses. The Clarkes each filed an answer and counterclaims for
33

Table of Contents
fraud and negligent misrepresentation and seek monetary damages in excess of $1 million, punitive damages, and attorneys’ fees. We will vigorously prosecute our claim and defend against the claims by the Clarkes.
Contractual Obligations
Our contractual obligations and commitments principally include obligations associated with our outstanding
indebtedness and obligations under operating leases. The table below summarizes our consolidated contractual cash obligations as of March 31, 2020:

|  | Payments Due
|  | Total |  | 2020 |  | 2021 |  | 2022 |  | 2023 |  | 2024 |  | Thereafter
|  | (In Thousands)
Long-term debt - TETRA |  | $ | 221,500 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 1,000 |  |  | $ | — |  |  | $ | 220,500 |
Long-term debt - CCLP |  | 649,430 |  |  | — |  |  | — |  |  | 295,930 |  |  | 3,500 |  |  | — |  |  | 350,000 |
Interest on debt - TETRA |  | 95,794 |  |  | 13,106 |  |  | 17,474 |  |  | 17,474 |  |  | 17,435 |  |  | 17,317 |  |  | 12,988 |
Interest on debt - CCLP |  | 185,387 |  |  | 35,779 |  |  | 47,705 |  |  | 40,593 |  |  | 26,310 |  |  | 26,250 |  |  | 8,750 |
Purchase obligations |  | 92,569 |  |  | 7,144 |  |  | 9,525 |  |  | 9,525 |  |  | 9,525 |  |  | 9,525 |  |  | 47,325 |
Asset retirement obligations(1) |  | 12,878 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 12,878 |
Operating leases |  | 117,891 |  |  | 19,961 |  |  | 22,092 |  |  | 18,422 |  |  | 14,776 |  |  | 12,372 |  |  | 30,268 |
Total contractual cash obligations(2) |  | $ | 1,375,449 |  |  | $ | 75,990 |  |  | $ | 96,796 |  |  | $ | 381,944 |  |  | $ | 72,546 |  |  | $ | 65,464 |  |  | $ | 682,709 |

(1) | We have estimated the timing of these payments for asset retirement obligation liabilities based upon our plans. The amounts shown represent the discounted obligation as of March 31, 2020.

(2) | Amounts exclude other long-term liabilities reflected in our Consolidated Balance Sheet that do not have known payment streams. These excluded amounts include approximately $0.4 million of liabilities under FASB Codification Topic 740, “Accounting for Uncertainty in Income Taxes,” as we are unable to reasonably estimate the ultimate amount or timing of settlements.

For additional information about our contractual obligations as of December 31, 2019, see "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2019 Annual Report on Form 10-K.
Cautionary Statement for Purposes of Forward-Looking Statements
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this Quarterly Report are identifiable by the use of the following words, the negative of such words, and other similar words: “anticipates", "assumes", “believes,” "budgets", “could,” “estimates,” "expects", "forecasts", "goal", "intends", "may", "might", "plans", "predicts", "projects", "schedules", "seeks", "should", "targets", "will", and "would".
Such forward-looking statements reflect our current views with respect to future events and financial performance and are based on assumptions that we believe to be reasonable, but such forward-looking statements are subject to numerous risks, and uncertainties, including, but not limited to:

• | economic and operating conditions that are outside of our control, including the trading price of our common stock;

• | the current significant surplus in the supply of oil and the ability of the OPEC and other oil producing nations to agree on and comply with supply limitations; the duration and magnitude of the unprecedented disruption in the oil and gas industry currently, which is negatively impacting our business;

• | the availability of adequate sources of capital to us;

• | expected customer drilling activity and capital spending for 2020 and 2021 and projections concerning our business activities

• | the levels of competition we encounter;

• | the planned closures of our El Dorado plant and CCLP’s Midland facility;

• | the availability of raw materials and labor at reasonable prices;

• | risks related to acquisitions and our growth strategy;

34

Table of Contents

• | restrictions under our debt agreements and the consequences of any failure to comply with debt covenants;

• | the effect and results of litigation, regulatory matters, settlements, audits, assessments, and contingencies;

• | risks related to our foreign operations;

• | information technology risks including the risk of cyberattack;

• | the severity and duration of the COVID-19 pandemic and related economic repercussions and the resulting negative impact on the demand for oil and gas;

• | operational challenges relating to the COVID-19 pandemic and efforts to mitigate the spread of the virus, including logistical challenges, protecting the health and well-being of our employees, remote work arrangements, performance of contracts, and supply chain disruptions;

• | other global or national health concerns, and

• | other risks and uncertainties under “Item 1A. Risk Factors” in our 2019 Annual Report, and as included in our other filings with the SEC, which are available free of charge on the SEC website at www.sec.gov.

The risks and uncertainties referred to above are generally beyond our ability to control and we cannot predict all the risks and uncertainties that could cause our actual results to differ from those indicated by the forward-looking statements. If any of these risks or uncertainties materialize, or if any of the underlying assumptions prove incorrect, actual results may vary from those indicated by the forward-looking statements, and such variances may be material.
All subsequent written and oral forward-looking statements made by or attributable to us or to persons acting on our behalf are expressly qualified in their entirety by reference to these risks and uncertainties. You should not place undue reliance on forward-looking statements. Each forward-looking statement speaks only as of the date of the particular statement, and we undertake no obligation to update or revise any forward-looking statements we may make, except as may be required by law.
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
Not Applicable.
Item 4. Controls and Procedures.
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2020, the end of the period covered by this quarterly report.
There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II
OTHER INFORMATION
Item 1. Legal Proceedings.
We are named defendants in several lawsuits and respondents in certain governmental proceedings arising in the ordinary course of business. While the outcome of lawsuits or other proceedings against us cannot be predicted with certainty, management does not consider it reasonably possible that a loss resulting from such lawsuits or other proceedings in excess of amounts accrued has been incurred that is expected to have a material adverse impact on our financial condition, results of operations, or liquidity.
35

Table of Contents
Item 1A. Risk Factors.
The statements in this section describe the known material risks to our business and should be considered carefully. We have described in the 2019 Annual Report significant risk factors and periodically update those risks for material developments. Provided below is an update to our risk factors as previously disclosed in the 2019 Annual Report.
The COVID-19 pandemic and oversupply of oil from OPEC+ has materially reduced demand for our products and services, and has had, and may continue to have, a significant adverse impact on our financial condition and results of operations.
The COVID-19 pandemic and subsequent mitigation efforts and disagreements between OPEC+ regarding limits of production of oil have added significant volatility and uncertainty in the oil and gas industry. At the outset of the pandemic, OPEC and the other oil producing nations were unable to reach an agreement on production levels for crude oil, which led both Russia and Saudi Arabia to substantially increase production. This, combined with an unprecedented decline in oil demand due to the COVID-19 pandemic, resulted in global oil markets being oversupplied. On April 12th, OPEC and the other oil producing nations reached an agreement to limit production through the end of June, although there still appears to be a large demand/supply imbalance. Despite the OPEC+ agreement to cut production, downward pressure on oil and natural gas prices remai ns and could continue for the foreseeable future. The collapse in the demand for oil caused by this unprecedented global health and economic crisis has had, and is reasonably likely to continue to have, a negative impact on the demand for our products and services. The decline in demand for our products and services has had, and is likely to continue to have, a negative impact on our financial condition and results of operations.
While the full impact of the COVID-19 pandemic is not yet known, we are closely monitoring the effects of the pandemic on our customers, our suppliers, our operations, and our employees. These effects have included, and may continue to include, declining revenue, disruptions to our operations, including customers canceling orders and returning our equipment early, customer shutdowns of oil and gas production activities, employee impacts from illness, school closures and other community response measures, and temporary closures of our facilities or the facilities of our customers and suppliers.
The extent to which our financial and operating results are negatively impacted by the COVID-19 pandemic and oversupplied oil markets will depend on various factors beyond our control, such as the duration and severity of the pandemic, additional measures taken by governments and our customers and suppliers in response to the pandemic, and the speed and effectiveness of mitigation efforts taken to combat the virus. For more information, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
If we cannot meet the continued listing requirements of the New York Stock Exchange (the “NYSE”), the NYSE may delist our common stock.
On March 26, 2020, we were notified by the New York Stock Exchange (the “NYSE”) that the average closing price of the TETRA’s common stock over the prior 30 consecutive trading day period was below $1.00 per share, which is the minimum average closing price per share required to maintain listing on the NYSE under Section 802.01C of the NYSE Listed Company Manual (“Section 802.01C”). We have a period of six months following receipt of the NYSE’s notice to regain compliance with the NYSE’s minimum share price requirement, during which time our shares continue to be listed and traded on the NYSE, subject to our compliance with other continued listing standards.
On April 20, 2020, the NYSE announced a rule change providing relief to listed companies that, due to market conditions resulting from the impact of the COVID-19 pandemic, have fallen out of compliance with certain of the NYSE’s continued listing standards. The NYSE has tolled the compliance period from April 20, 2020 through June 30, 2020, which has the effect of extending the available cure period. The cure period will recommence on July 1, 2020. If we fail to regain compliance with Section 802.01C by December 5, 2020, which is the end of our extended cure period, our shares will be subject to the NYSE’s suspension and delisting procedures. If necessary to regain compliance with NYSE listing standards, we may, subject to approval of our board of directors and stockholders, implement a reverse stock split. A delisting of our shares from the NYSE could negatively impact us by, among other things, reducing the liquidity and market price of our shares, reducing the number of investors willing to hold or acquire our shares, limiting our ability to issue securities or obtain financing in the future, and limiting our ability to
36

Table of Contents
use a registration statement to offer and sell freely tradable securities, thereby restricting our ability to access the public capital markets.
In addition, the NYSE has other continued listing criteria that we are at risk of violating. For example, continued declines in the market price of our shares could result in a delisting under the NYSE’s “abnormally low selling price” criteria, which the NYSE typically views to be a trading price of less than $0.16 per share, or its minimum average market capitalization requirement of $15.0 million. The NYSE has suspended through June 30, 2020 its rule that would immediately begin delisting procedures against companies with an average global market capitalization of under $15 million over a 30-trading day period. There are no assurances that suspension will be extended. On May 5, 2020, the trading price of our common stock closed at $0.55 per share and our market capitalization was $69.2 million.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
(a) None.
(b) None.
(c) Purchases of Equity Securities by the Issuer and Affiliated Purchasers.

Period |  | Total Number of Shares Purchased |  | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1) |  | Maximum Number (or Approximate Dollar Value) of Shares that May Yet be Purchased Under the Publicly Announced Plans or Programs(1)
January 1 – January 31, 2020 |  | — |  |  | $ | — |  | — |  |  | $ | 14,327,000 |
February 1 – February 29, 2020 |  | 73,436 |  | (2) | 1.22 |  | — |  |  | 14,327,000 |
March 1 – March 31, 2020 |  | — |  |  | — |  | — |  |  | 14,327,000 |
Total |  | 73,436 |  |  |  |  | — |  |  | $ | 14,327,000 |

(1) | In January 2004, our Board of Directors authorized the repurchase of up to $20 million of our common stock. Purchases will be made from time to time in open market transactions at prevailing market prices. The repurchase program may continue until the authorized limit is reached, at which time the Board of Directors may review the option of increasing the authorized limit.

(2) | Shares we received in connection with the exercise of certain employee stock options or the vesting of certain shares of employee restricted stock. These shares were not acquired pursuant to the stock repurchase program.

Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
None.
Item 5. Other Information.
None.
37

Table of Contents
Item 6. Exhibits.
Exhibits:

31.1* | Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2* | Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1** | Certification Furnished Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2** | Certification Furnished Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.SCH+ | XBRL Taxonomy Extension Schema Document.
101.CAL+ | XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB+ | XBRL Taxonomy Extension Label Linkbase Document.
101.PRE+ | XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF+ | XBRL Taxonomy Extension Definition Linkbase Document.

* | Filed with this report.

** | Furnished with this report.

+ | Attached as Exhibit 101 to this report are the following documents formatted in XBRL (Extensible Business Reporting Language): (i) Consolidated Statements of Operations for the three month periods ended March 31, 2020 and 2019; (ii) Consolidated Statements of Comprehensive Income for the three month periods ended March 31, 2020 and 2019; (iii) Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019; (iv) Consolidated Statements of Cash Flows for the three month periods ended March 31, 2020 and 2019; and (v) Notes to Consolidated Financial Statements for the three months ended March 31, 2020.

38

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | TETRA Technologies, Inc.
Date: | May 7, 2020 | By: | /s/Brady M. Murphy
|  |  | Brady M. Murphy
|  |  | President
|  |  | Chief Executive Officer
Date: | May 7, 2020 | By: | /s/Elijio V. Serrano
|  |  | Elijio V. Serrano
|  |  | Senior Vice President
|  |  | Chief Financial Officer
Date: | May 7, 2020 | By: | /s/Richard D. O'Brien
|  |  | Richard D. O'Brien
|  |  | Vice President – Finance and Global Controller
|  |  | Principal Accounting Officer

39